US20220214612A1 - Agglutinant for Pellicle, Pellicle, Exposure Original Plate with Pellicle, Method for Producing Semiconductor Device, Method for Producing Liquid Crystal Display Board, Method for Regenerating Exposure Original Plate, and Peeling Residue Reduction Method - Google Patents
Agglutinant for Pellicle, Pellicle, Exposure Original Plate with Pellicle, Method for Producing Semiconductor Device, Method for Producing Liquid Crystal Display Board, Method for Regenerating Exposure Original Plate, and Peeling Residue Reduction Method Download PDFInfo
- Publication number
- US20220214612A1 US20220214612A1 US17/603,932 US202017603932A US2022214612A1 US 20220214612 A1 US20220214612 A1 US 20220214612A1 US 202017603932 A US202017603932 A US 202017603932A US 2022214612 A1 US2022214612 A1 US 2022214612A1
- Authority
- US
- United States
- Prior art keywords
- pellicle
- agglutinant
- original plate
- exposure original
- exposure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 27
- 230000009467 reduction Effects 0.000 title claims abstract description 16
- 230000001172 regenerating effect Effects 0.000 title claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 title claims description 22
- 239000004973 liquid crystal related substance Substances 0.000 title claims description 12
- 239000004065 semiconductor Substances 0.000 title claims description 12
- 229920000058 polyacrylate Polymers 0.000 claims abstract description 78
- 239000000463 material Substances 0.000 claims abstract description 49
- 238000004140 cleaning Methods 0.000 claims description 44
- 239000000758 substrate Substances 0.000 claims description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 239000000178 monomer Substances 0.000 claims description 27
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 26
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 22
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 15
- 230000010363 phase shift Effects 0.000 claims description 13
- 230000008929 regeneration Effects 0.000 claims description 12
- 238000011069 regeneration method Methods 0.000 claims description 12
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 9
- 125000002947 alkylene group Chemical group 0.000 claims description 9
- 229910052814 silicon oxide Inorganic materials 0.000 claims description 9
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 239000010453 quartz Substances 0.000 claims description 6
- 238000001459 lithography Methods 0.000 abstract description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 30
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 26
- 150000001875 compounds Chemical class 0.000 description 16
- 239000000853 adhesive Substances 0.000 description 15
- 230000001070 adhesive effect Effects 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- -1 polyethylene Polymers 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 9
- 239000000428 dust Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000015556 catabolic process Effects 0.000 description 8
- 239000011248 coating agent Substances 0.000 description 8
- 238000000576 coating method Methods 0.000 description 8
- 238000006731 degradation reaction Methods 0.000 description 8
- 229920001289 polyvinyl ether Polymers 0.000 description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000006866 deterioration Effects 0.000 description 6
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 239000004925 Acrylic resin Substances 0.000 description 5
- 229920000178 Acrylic resin Polymers 0.000 description 5
- 229910000838 Al alloy Inorganic materials 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 5
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical group C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 5
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 229910001873 dinitrogen Inorganic materials 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229920001228 polyisocyanate Polymers 0.000 description 5
- 239000005056 polyisocyanate Substances 0.000 description 5
- 239000003505 polymerization initiator Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- HFCUBKYHMMPGBY-UHFFFAOYSA-N 2-methoxyethyl prop-2-enoate Chemical compound COCCOC(=O)C=C HFCUBKYHMMPGBY-UHFFFAOYSA-N 0.000 description 3
- 239000004129 EU approved improving agent Substances 0.000 description 3
- 239000004593 Epoxy Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- 239000012948 isocyanate Chemical class 0.000 description 3
- 150000002513 isocyanates Chemical class 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000007788 roughening Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- UZKWTJUDCOPSNM-UHFFFAOYSA-N 1-ethenoxybutane Chemical compound CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 2
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 2
- 125000001033 ether group Chemical group 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229920002313 fluoropolymer Polymers 0.000 description 2
- 239000004811 fluoropolymer Substances 0.000 description 2
- XEMZLVDIUVCKGL-UHFFFAOYSA-N hydrogen peroxide;sulfuric acid Chemical compound OO.OS(O)(=O)=O XEMZLVDIUVCKGL-UHFFFAOYSA-N 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 2
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 2
- 229920002120 photoresistant polymer Polymers 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 238000004506 ultrasonic cleaning Methods 0.000 description 2
- FKTHNVSLHLHISI-UHFFFAOYSA-N 1,2-bis(isocyanatomethyl)benzene Chemical compound O=C=NCC1=CC=CC=C1CN=C=O FKTHNVSLHLHISI-UHFFFAOYSA-N 0.000 description 1
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- GXZPMXGRNUXGHN-UHFFFAOYSA-N 1-ethenoxy-2-methoxyethane Chemical compound COCCOC=C GXZPMXGRNUXGHN-UHFFFAOYSA-N 0.000 description 1
- OZCMOJQQLBXBKI-UHFFFAOYSA-N 1-ethenoxy-2-methylpropane Chemical compound CC(C)COC=C OZCMOJQQLBXBKI-UHFFFAOYSA-N 0.000 description 1
- SDXHBDVTZNMBEW-UHFFFAOYSA-N 1-ethoxy-2-(2-hydroxyethoxy)ethanol Chemical compound CCOC(O)COCCO SDXHBDVTZNMBEW-UHFFFAOYSA-N 0.000 description 1
- NKVCQMYWYHDOOF-UHFFFAOYSA-N 1-phenoxyethane-1,2-diol Chemical compound OCC(O)OC1=CC=CC=C1 NKVCQMYWYHDOOF-UHFFFAOYSA-N 0.000 description 1
- IVIDDMGBRCPGLJ-UHFFFAOYSA-N 2,3-bis(oxiran-2-ylmethoxy)propan-1-ol Chemical compound C1OC1COC(CO)COCC1CO1 IVIDDMGBRCPGLJ-UHFFFAOYSA-N 0.000 description 1
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 1
- YHYCMHWTYHPIQS-UHFFFAOYSA-N 2-(2-hydroxyethoxy)-1-methoxyethanol Chemical compound COC(O)COCCO YHYCMHWTYHPIQS-UHFFFAOYSA-N 0.000 description 1
- HLIQLHSBZXDKLV-UHFFFAOYSA-N 2-(2-hydroxyethoxy)-1-phenoxyethanol Chemical compound OCCOCC(O)OC1=CC=CC=C1 HLIQLHSBZXDKLV-UHFFFAOYSA-N 0.000 description 1
- SYEWHONLFGZGLK-UHFFFAOYSA-N 2-[1,3-bis(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COCC(OCC1OC1)COCC1CO1 SYEWHONLFGZGLK-UHFFFAOYSA-N 0.000 description 1
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 1
- WTYYGFLRBWMFRY-UHFFFAOYSA-N 2-[6-(oxiran-2-ylmethoxy)hexoxymethyl]oxirane Chemical compound C1OC1COCCCCCCOCC1CO1 WTYYGFLRBWMFRY-UHFFFAOYSA-N 0.000 description 1
- FWWXYLGCHHIKNY-UHFFFAOYSA-N 2-ethoxyethyl prop-2-enoate Chemical compound CCOCCOC(=O)C=C FWWXYLGCHHIKNY-UHFFFAOYSA-N 0.000 description 1
- NJRHMGPRPPEGQL-UHFFFAOYSA-N 2-hydroxybutyl prop-2-enoate Chemical compound CCC(O)COC(=O)C=C NJRHMGPRPPEGQL-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- MECNWXGGNCJFQJ-UHFFFAOYSA-N 3-piperidin-1-ylpropane-1,2-diol Chemical compound OCC(O)CN1CCCCC1 MECNWXGGNCJFQJ-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229920003180 amino resin Polymers 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- SWXQKHHHCFXQJF-UHFFFAOYSA-N azane;hydrogen peroxide Chemical compound [NH4+].[O-]O SWXQKHHHCFXQJF-UHFFFAOYSA-N 0.000 description 1
- 150000001541 aziridines Chemical class 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 238000012662 bulk polymerization Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000007974 melamines Chemical class 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- JAYXSROKFZAHRQ-UHFFFAOYSA-N n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1CN(C=1C=CC=CC=1)CC1CO1 JAYXSROKFZAHRQ-UHFFFAOYSA-N 0.000 description 1
- SJPFBRJHYRBAGV-UHFFFAOYSA-N n-[[3-[[bis(oxiran-2-ylmethyl)amino]methyl]phenyl]methyl]-1-(oxiran-2-yl)-n-(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CN(CC=1C=C(CN(CC2OC2)CC2OC2)C=CC=1)CC1CO1 SJPFBRJHYRBAGV-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002101 nanobubble Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- AFEQENGXSMURHA-UHFFFAOYSA-N oxiran-2-ylmethanamine Chemical compound NCC1CO1 AFEQENGXSMURHA-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005488 sandblasting Methods 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 150000007934 α,β-unsaturated carboxylic acids Chemical class 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J7/00—Adhesives in the form of films or foils
- C09J7/30—Adhesives in the form of films or foils characterised by the adhesive composition
- C09J7/38—Pressure-sensitive adhesives [PSA]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/28—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety
- C08F220/281—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety and containing only one oxygen, e.g. furfuryl (meth)acrylate or 2-methoxyethyl (meth)acrylate
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J11/00—Features of adhesives not provided for in group C09J9/00, e.g. additives
- C09J11/08—Macromolecular additives
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J129/00—Adhesives based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal, or ketal radical; Adhesives based on hydrolysed polymers of esters of unsaturated alcohols with saturated carboxylic acids; Adhesives based on derivatives of such polymers
- C09J129/10—Homopolymers or copolymers of unsaturated ethers
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J133/00—Adhesives based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Adhesives based on derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J133/00—Adhesives based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Adhesives based on derivatives of such polymers
- C09J133/04—Homopolymers or copolymers of esters
- C09J133/14—Homopolymers or copolymers of esters of esters containing halogen, nitrogen, sulfur or oxygen atoms in addition to the carboxy oxygen
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F1/00—Originals for photomechanical production of textured or patterned surfaces, e.g., masks, photo-masks, reticles; Mask blanks or pellicles therefor; Containers specially adapted therefor; Preparation thereof
- G03F1/26—Phase shift masks [PSM]; PSM blanks; Preparation thereof
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F1/00—Originals for photomechanical production of textured or patterned surfaces, e.g., masks, photo-masks, reticles; Mask blanks or pellicles therefor; Containers specially adapted therefor; Preparation thereof
- G03F1/62—Pellicles, e.g. pellicle assemblies, e.g. having membrane on support frame; Preparation thereof
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F1/00—Originals for photomechanical production of textured or patterned surfaces, e.g., masks, photo-masks, reticles; Mask blanks or pellicles therefor; Containers specially adapted therefor; Preparation thereof
- G03F1/62—Pellicles, e.g. pellicle assemblies, e.g. having membrane on support frame; Preparation thereof
- G03F1/64—Pellicles, e.g. pellicle assemblies, e.g. having membrane on support frame; Preparation thereof characterised by the frames, e.g. structure or material, including bonding means therefor
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F1/00—Originals for photomechanical production of textured or patterned surfaces, e.g., masks, photo-masks, reticles; Mask blanks or pellicles therefor; Containers specially adapted therefor; Preparation thereof
- G03F1/66—Containers specially adapted for masks, mask blanks or pellicles; Preparation thereof
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/20—Exposure; Apparatus therefor
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/70—Microphotolithographic exposure; Apparatus therefor
- G03F7/708—Construction of apparatus, e.g. environment aspects, hygiene aspects or materials
- G03F7/70983—Optical system protection, e.g. pellicles or removable covers for protection of mask
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
- H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
- H01L21/027—Making masks on semiconductor bodies for further photolithographic processing not provided for in group H01L21/18 or H01L21/34
- H01L21/0271—Making masks on semiconductor bodies for further photolithographic processing not provided for in group H01L21/18 or H01L21/34 comprising organic layers
- H01L21/0273—Making masks on semiconductor bodies for further photolithographic processing not provided for in group H01L21/18 or H01L21/34 comprising organic layers characterised by the treatment of photoresist layers
- H01L21/0274—Photolithographic processes
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
- H01L21/67—Apparatus specially adapted for handling semiconductor or electric solid state devices during manufacture or treatment thereof; Apparatus specially adapted for handling wafers during manufacture or treatment of semiconductor or electric solid state devices or components ; Apparatus not specifically provided for elsewhere
- H01L21/683—Apparatus specially adapted for handling semiconductor or electric solid state devices during manufacture or treatment thereof; Apparatus specially adapted for handling wafers during manufacture or treatment of semiconductor or electric solid state devices or components ; Apparatus not specifically provided for elsewhere for supporting or gripping
Definitions
- the present invention relates to an agglutinant for pellicles, a pellicle, an exposure original plate with a pellicle, a method for producing a semiconductor device, a method for producing a liquid crystal display board, a method for regenerating an exposure original plate, and a peeling residue reduction method.
- a pattern is made by irradiating light to a semiconductor wafer or an original plate for liquid crystal, but if dust is attached to an exposure original plate used in this case, the dust absorbs the light or bends the light.
- the transferred pattern would be deformed, and the resulting pattern would have roughened edges or black stains on the base, which would lead to problems such as damaged dimensions, poor quality, and deformed external appearance.
- the “exposure original plate” is a generic name of lithography masks and reticles.
- the dust does not directly adhere to the surface of the exposure original plate but adhere only to the pellicle film. Accordingly, when the focus is set on the pattern of the exposure original plate during lithography, the dust on the pellicle film becomes irrelevant to transfer.
- the basic structure of the pellicle comprises a pellicle frame and a pellicle film stretched over the pellicle frame.
- the pellicle film is made of nitrocellulose, cellulose acetate, a fluorine-based polymer, or the like that well transmits light used for exposure (g-rays, i-rays, 248 nm, 193 nm, 157 nm, etc.).
- the pellicle frame is made of an aluminum alloy such as A7075, A6061, or A5052 treated with black alumite or the like, stainless steel, polyethylene, or the like.
- a good solvent of a pellicle film is applied to the upper part of the pellicle frame, and the pellicle film is bonded by air-drying or using an adhesive material such as an acrylic resin, an epoxy resin, or fluororesin. Further, since the lower part of the pellicle frame is mounted with an exposure original plate, an agglutinant layer obtained from a polybutene resin, a polyvinyl acetate resin, an acrylic resin, a silicone resin, or the like, and a protective liner for protecting the agglutinant layer are provided.
- the pellicle is provided so as to surround a pattern region formed on the surface of the exposure original plate. Since the pellicle is provided to prevent the adhesion of dust to the exposure original plate, the pattern region and the outside of the pellicle are isolated from each other so that dust from the outside of the pellicle does not adhere to the pattern surface.
- phase shift films have been commonly used as mask substrate films to meet the miniaturization of design rules.
- phase shift films are very delicate, and mask cleaning under excessive conditions may cause damage, such as corrosion and scraping, to the phase shift films. For this reason, in recent years, there has been a tendency to reconsider chemicals used for mask cleaning, and to weaken the cleaning conditions.
- the mask pattern of advanced mask products is shifting from positive type mask patterns, which have been the mainstream until now, to negative type mask patterns.
- no light-shading layer is provided in the portion to which the pellicle is bonded. If there is no light-shading layer, there is a possibility that the pellicle agglutinant is irradiated with an exposure light beam through the mask substrate. In that case, more residues of the agglutinant layer may remain on the mask substrate when the pellicle is peeled.
- pellicle a new pellicle (which is hereinafter referred to as “repellicle”). It is the most important for repellicle that regeneration cleaning is performed so that the mask is kept in a state of high cleanliness; however, in order to carry out regeneration cleaning of the mask under recent weak cleaning conditions, it is important to reduce residues remaining on the mask substrate when the pellicle is peeled.
- regeneration cleaning cleaning with chemicals such as sulfuric acid hydrogen peroxide or ammonia hydrogen peroxide, and physical cleaning by brushes, sponges, or the like are generally used.
- regeneration cleaning with functional water is being studied to prevent damage to photo masks and sulfate ions from remaining on the photo masks.
- Functional water is generally defined by the Japanese Society for Functional Water as, among aqueous solutions that have been given reproducible and useful functions by artificial treatment, those for which the scientific basis for treatment and function has been clarified, and those for which such scientific basis is about to be clarified.
- Specific examples thereof include fine bubble water such as ozone water, hydrogen water, micro-bubble water, and nano-bubble water; electrolyzed water, supercritical water, subcritical water, and the like.
- Ozone water and hydrogen water are often used to clean photo masks.
- the cleaning power can be improved by adding a small amount of ammonia.
- IP Publications 1 and 2 Attempts have been made so far to reduce residues by adding surface modifiers or the like to agglutinants. Further, as techniques of reducing residues, a large pellicle having an agglutinant layer with a cohesive fracture strength of 20 g/mm 2 or more (IP Publication 3 described above), and a pellicle comprising an agglutinant for pellicles and having a ratio of peeling strength and tensile strength of 0.10 or more and 0.33 or less are disclosed (IP Publication 4 described above).
- the present invention was made in view of such circumstances, and an object of the present invention is to provide an agglutinant for pellicles that can reduce residues stuck onto an exposure original plate when a pellicle is peeled from the exposure original plate after being used in lithography, in particular ArF lithography, and to also provide a pellicle, an exposure original plate with a pellicle, a method for regenerating an exposure original plate, and a peeling residue reduction method.
- Another object of the present invention is to provide a method for producing a semiconductor device and a method for producing a liquid crystal display board that can thereby improve production efficiency.
- An agglutinant for pellicles for bonding a pellicle to an exposure original plate comprising an acrylic polymer having an SP value of 10.0 or more and 12.0 or less as a base material.
- An agglutinant for pellicles for bonding a pellicle to an exposure original plate comprising an acrylic polymer as a base material, the acrylic polymer comprising a (meth)acrylic acid ester having an ether bond as a monomer component.
- An agglutinant for pellicles for bonding a pellicle to an exposure original plate comprising an acrylic polymer as a base material, the acrylic polymer having a side chain containing an ether bond.
- An agglutinant for pellicles for bonding a pellicle to an exposure original plate comprising an acrylic polymer as a base material, the acrylic polymer having a side chain that has higher degradability by irradiation with an exposure light beam than a main chain.
- An agglutinant for pellicles for bonding a pellicle to an exposure original plate comprising an acrylic polymer as a base material, the acrylic polymer having a side chain that is selectively degraded by irradiation with an exposure light beam.
- a pellicle frame with an agglutinant layer comprising a pellicle frame and an agglutinant layer provided on one end face of the pellicle frame and obtained from an agglutinant for pellicles as claimed in any one of [1] to [12] described above.
- a pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film on one end face thereof, and an agglutinant layer provided on the other end face of the pellicle frame and obtained from an agglutinant for pellicles as claimed in any one of [1] to [12] described above.
- An exposure original plate with a pellicle comprising an exposure original plate and a pellicle as claimed in [14] or [15] described above mounted on the exposure original plate.
- a method for producing a semiconductor device comprising a step of performing exposure using an exposure original plate with a pellicle as claimed in any one of [23] to [29] described above.
- a method for producing a liquid crystal display board comprising a step of performing exposure using an exposure original plate with a pellicle as claimed in any one of [23] to [29] described above.
- a method for regenerating an exposure original plate comprising peeling a pellicle from an exposure original plate with a pellicle as claimed in any one of [23] to [29] described above, and cleaning residues of an agglutinant remaining on the exposure original plate with functional water to regenerate the exposure original plate.
- a peeling residue reduction method comprising, when peeling a pellicle from an exposure original plate to which the pellicle is bonded, reducing peeling residues of an agglutinant layer of the pellicle remaining on the exposure original plate, wherein the method uses a pellicle as claimed in any one of [14] to [22] described above as the pellicle.
- a pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film on one end face thereof, and an agglutinant layer provided on the other end face of the pellicle frame and obtained from an agglutinant for the pellicle, wherein the agglutinant layer is irradiated with an exposure light beam.
- a pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film on one end face thereof, and an agglutinant layer provided on the other end face of the pellicle frame and obtained from an agglutinant for the pellicle, wherein the pellicle is bonded to a phase shift photo mask.
- a pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film on one end face thereof, and an agglutinant layer provided on the other end face of the pellicle frame and obtained from an agglutinant for the pellicle, wherein the pellicle is bonded to a negative type exposure original plate.
- a pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film on one end face thereof, and an agglutinant layer provided on the other end face of the pellicle frame and obtained from an agglutinant for the pellicle, wherein the pellicle is bonded to an exposure original plate that has a non-shaded area or a semi-transparent shaded area in a portion thereof to which the agglutinant layer is bonded.
- a pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film on one end face thereof, and an agglutinant layer provided on the other end face of the pellicle frame and obtained from an agglutinant for the pellicle, wherein the pellicle is bonded to an exposure original plate that has a transparent area in a portion thereof to which the agglutinant layer is bonded.
- a pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film on one end face thereof, and an agglutinant layer provided on the other end face of the pellicle frame and obtained from an agglutinant for the pellicle, wherein the pellicle is bonded to a face comprising silicon oxide as a main component (in particular, a quartz face).
- a pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film on one end face thereof, and an agglutinant layer provided on the other end face of the pellicle frame and obtained from an agglutinant for the pellicle, wherein the pellicle is compatible with regeneration cleaning with functional water.
- a peeling residue reduction pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film bonded to one end face thereof, and an agglutinant layer for bonding the pellicle provided on the other end face of the pellicle frame to an exposure original plate, wherein the agglutinant layer comprises an acrylic resin having an SP value of 10.0 or more and 12.0 or less as a base material.
- peeling residue reduction pellicle as claimed in [41] or [42] described above, wherein the peeling residue reduction pellicle is a peeling residue reduction pellicle for ArF lithography.
- a method for producing a peeling residue reduction pellicle comprising selecting an agglutinant for bonding the pellicle to an exposure original plate, applying the agglutinant to one end face of a pellicle frame to form an agglutinant layer, peelably bonding a protective member thereto, applying an adhesive material to the other end face of the pellicle frame, and bonding a pellicle film thereto, wherein in selection of the agglutinant, one comprising an acrylic resin having an SP value of 10.0 or more and 12.0 or less as a base material is selected.
- the present invention can provide a pellicle that can reduce peeling residues stuck onto an exposure original plate when a pellicle is peeled from the exposure original plate after being used in lithography, in particular ArF lithography, and can also provide an exposure original plate with a pellicle, a method for regenerating an exposure original plate, and a peeling residue reduction method.
- the pellicle, exposure original plate with a pellicle, method for regenerating an exposure original plate, and peeling residue reduction method of the present invention even when an exposure light beam is applied through the exposure original plate, the pellicle can be peeled from the exposure original plate with very few peeling residues of the agglutinant.
- the regeneration cleaning of the exposure original plate, from which the pellicle is removed can proceed smoothly, and the cleaning conditions can be loosened; thus, there is an advantage in reducing damage to the exposure original plate surface during cleaning.
- production efficiency can be improved in the production of semiconductor devices and liquid crystal display boards.
- the pellicle of the present invention it is assumed that since a specific acrylic polymer (also referred to as an acrylic resin) is used as the base material of the agglutinant, the intermolecular force inside the agglutinant is improved, appropriate adhesive strength can be maintained, and not only large residues but also particulate residues are reduced during peeling from the exposure original plate.
- a specific acrylic polymer also referred to as an acrylic resin
- FIG. 1 A conceptual diagram showing the basic structure of the pellicle of the present invention.
- the pellicle 10 of the present invention is such that a pellicle film 12 is stretched over the upper end face of a pellicle frame 11 through an adhesive material layer 13 for bonding the pellicle film.
- an agglutinant layer 14 for bonding the pellicle 10 to an exposure original plate (mask substrate or reticle) 1 is generally formed on the lower end face of the pellicle frame 11 , and a liner (not shown) is peelably bonded to the lower end face of the agglutinant layer 14 .
- the pellicle frame 11 may be provided with an air pressure adjustment hole (vent) 15 , and may be further provided with a dust removal filter 16 for the purpose of removing particles.
- the size of these pellicle constituent members is equivalent to that of general pellicles, for example, pellicles for semiconductor lithography and pellicles for the lithography step in the production of large liquid crystal display boards.
- the materials thereof can be known materials as described above.
- the type of pellicle film 12 is not particularly limited.
- amorphous fluoropolymers conventionally used for excimer laser are used.
- amorphous fluoropolymers include Cytop (trade name of AGC Inc.), Teflon (registered trademark) AF (trade name of DuPont), and the like. These polymers may be used after being dissolved in solvents, if necessary, during the production of pellicle films, and can be suitably dissolved, for example, in fluorine type solvents.
- the base material of the pellicle frame 11 for example, aluminum alloy materials, preferably JIS A7075, JIS A6061, and JIS A5052 materials, are used.
- aluminum alloy materials preferably JIS A7075, JIS A6061, and JIS A5052 materials.
- the pellicle frame surface is preferably roughened by sandblasting or chemical polishing, and a polymer coating may be provided after roughening.
- a conventionally known method can be employed as the method for roughening the frame surface.
- the surface of an aluminum alloy material is subjected to blast treatment using stainless steel, carborundum, glass beads, or the like, and is further subjected to chemical polishing using NaOH or the like, thereby roughening the surface.
- the present inventors conducted many discussions and experiments in order to solve the above problems of the present invention, particularly focused on the feature of the agglutinant forming the agglutinant layer, and comparatively analyzed the experimental results. As a result, the present inventors found that the following means was effective.
- a first aspect of the agglutinant for pellicles of the present invention is to use an acrylic polymer having an SP value of 10.0 or more and 12.0 or less as a base material. Due to the acrylic polymer having an SP value of 10.0 or more and 12.0 or less, when the pellicle is peeled from the exposure original plate, peeling residues of the agglutinant layer remaining on the exposure original plate can be reduced. When the SP value is 10.0 or more, residues that can hardly be removed by cleaning can be reduced. On the other hand, when the SP value is 12.0 or less, the volatility of the agglutinant can be reduced, which leads to the suppression of haze.
- the present inventors assume that the effects of the present invention can be obtained by improving the hydrophilicity of the acrylic polymer by setting the SP value within the specific range.
- a second aspect of the agglutinant for pellicles of the present invention is to use, as a base material, an acrylic polymer comprising a (meth)acrylic acid ester having an ether bond as a monomer component. Because a (meth)acrylic acid ester having an ether bond is contained as a monomer component of an acrylic polymer, when the pellicle is peeled from the exposure original plate, peeling residues of the agglutinant layer remaining on the exposure original plate can be reduced. Due to the introduction of an ether bond into an acrylic polymer, it becomes easy to control the hydrophilicity of the acrylic polymer. In addition, due to the introduction of an ether bond into the side chain of an acrylic polymer, the ether bond is assumed to prevent light-deterioration of the main chain.
- a third aspect of the agglutinant for pellicles of the present invention is to use, as a base material, an acrylic polymer having a side chain containing an ether bond. Because an ether bond is contained in the side chain of an acrylic polymer, when the pellicle is peeled from the exposure original plate, peeling residues of the agglutinant layer remaining on the exposure original plate can be reduced. Due to the introduction of an ether bond into an acrylic polymer, it becomes easy to control the hydrophilicity of the acrylic polymer. In addition, the introduction of an ether bond into the side chain of an acrylic polymer is assumed to prevent light-deterioration of the main chain.
- a fourth aspect of the agglutinant for pellicles of the present invention is to use, as a base material, an acrylic polymer having a side chain that has higher degradability by irradiation with an exposure light beam than a main chain. Because the degradability of the side chain of the acrylic polymer by irradiation with an exposure light beam is higher than that of the main chain, when the pellicle is peeled from the exposure original plate, peeling residues of the agglutinant layer remaining on the exposure original plate can be reduced. It is assumed that since the degradability of the side chain by the exposure light beam is higher than that of the main chain, the degradation of the side chain substantially precedes the degradation of the main chain, and peeling residues can be reduced.
- the degradation of the side chain has less effect on the deterioration of the agglutinant, and even if the degradation proceeds, it is considered that the agglutinant is less likely to remain as peeling residues during peeling due to the cohesive force of the agglutinant.
- the molecular weight of the main chain is reduced, and it is considered that the reduced-molecular-weight agglutinant remains on the substrate as residues.
- the difference in degradability can be determined, for example, by comparing the decomposition product of the main chain and the decomposition product of the side chain before and after irradiation of the agglutinant with an exposure light beam by IR, NMR, or the like. More specifically, it can be confirmed by comparing the IR chart of the agglutinant before irradiation with an exposure light beam with the IR chart of the agglutinant after irradiation with an exposure light beam, and observing the change in spectral intensity.
- Examples of the wave number to be confirmed include C—O—C (methoxy group) at 1125 cm ⁇ 1 , C—O—C (ether group) at 1160 cm ⁇ 1 , C ⁇ O (ester group) at 1727 cm ⁇ 1 , and the like.
- a fifth aspect of the agglutinant for pellicles of the present invention is to use, as a base material, an acrylic polymer having a side chain that is selectively deteriorated by irradiation with an exposure light beam. Because the side chain of the acrylic polymer is selectively deteriorated by irradiation with an exposure light beam, when the pellicle is peeled from the exposure original plate, peeling residues of the agglutinant layer remaining on the exposure original plate can be reduced. It is assumed that since the side chain is selectively deteriorated by irradiation with an exposure light beam, the degradation of the side chain substantially precedes the degradation of the main chain, and peeling residues can be reduced.
- the degradation of the side chain has relatively less effect on the deterioration of the agglutinant, and even if the degradation proceeds, it is considered that the agglutinant is less likely to remain as peeling residues during peeling due to the cohesive force of the agglutinant.
- the molecular weight of the main chain is reduced, and it is considered that the reduced-molecular-weight agglutinant remains on the substrate as residues.
- the presence of deterioration can be determined, for example, by comparing the decomposition product of the main chain and the decomposition product of the side chain before and after irradiation of the agglutinant with an exposure light beam by IR, NMR, or the like. More specifically, it can be confirmed by comparing the IR chart of the agglutinant before irradiation with an exposure light beam with the IR chart of the agglutinant after irradiation with an exposure light beam, and observing the change in spectral intensity.
- Examples of the wave number to be confirmed include C—O—C (methoxy group) at 1125 cm ⁇ 1 , C—O—C (ether group) at 1160 cm ⁇ 1 , C ⁇ O (ester group) at 1727 cm ⁇ 1 , and the like.
- the “agglutinant comprising an acrylic polymer as a base material” refers to an agglutinant containing an acrylic polymer itself or an agglutinant containing a reaction product of the acrylic polymer, a curing agent, and the like.
- the present inventors found that in a pellicle provided with an agglutinant layer obtained from such an agglutinant, the agglutinant layer suppressed deterioration due to an exposure light beam, and that even if deterioration occurred, peeling residues were less likely to be generated during peeling from the mask substrate (exposure original plate).
- the acrylic polymer mentioned above is, for example, a polymer comprising a (meth)acrylic acid ester as a monomer component, and a monomer component copolymerizable with the (meth)acrylic acid ester can be copolymerized, if necessary.
- the (meth)acrylic acid ester include (meth)acrylic acid esters having an ether bond, (meth)acrylic acid alkyl esters, unsaturated monomers having a carboxyl group or a hydroxyl group, and the like.
- the ether bond can be introduced into the side chain of the acrylic polymer.
- Examples of the (meth)acrylic acid ester having an ether bond ((A) component) include (meth)acrylic acid esters having an alkylene oxide group, such as an ethylene oxide group, a propylene oxide group, or a butylene oxide group. Among these, (meth)acrylic acid esters having an ethylene oxide group (also referred to as ethylene oxide group-containing (meth)acrylates) are preferable.
- methoxypolyethylene glycol (meth)acrylates such as 2-methoxyethyl (meth)acrylate, 2-ethoxyethyl (meth)acrylate, 2-butoxyethyl (meth)acrylate, phenoxyethylene glycol (meth)acrylate, and methoxydiethylene glycol (meth)acrylate
- ethoxypolyethylene glycol (meth)acrylates such as ethoxydiethylene glycol (meth)acrylate
- butoxypolyethylene glycol (meth)acrylates such as butoxydiethylene glycol (meth)acrylate
- phenoxypolyethylene glycol (meth)acrylates such as phenoxydiethylene glycol (meth)acrylate; and the like.
- Examples of the (meth)acrylic acid alkyl ester ((B) component) include (meth)acrylic acid alkyl esters having a C 1-14 alkyl group, and the like. Specific examples thereof include methyl (meth)acrylate, ethyl (meth)acrylate, propyl (meth)acrylate, n-butyl (meth)acrylate, isobutyl (meth)acrylate, isoamyl (meth)acrylate, hexyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, n-octyl (meth)acrylate, isooctyl (meth)acrylate, isononyl (meth)acrylate, lauryl (meth)acrylate, and the like. Among these, (meth)acrylic acid alkyl esters having a C 4 or C 8 alkyl group are preferable, in terms of satisfying both agglutinant characteristics and peeling characteristics. These
- Examples of the unsaturated monomer having a carboxyl group or a hydroxyl group ((C) component) include ⁇ , ⁇ -unsaturated carboxylic acids, such as (meth)acrylic acid, maleic acid, crotonic acid, itaconic acid, and fumaric acid; hydroxyl group-containing methacrylates, such as 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, and 2-hydroxybutyl (meth)acrylate; and the like. These may be used singly or in combination of two or more.
- the ratio of the (A) component used in the acrylic polymer is preferably 30 mass % or more, more preferably 35 mass % or more, particularly preferably 35 to 98 mass %, and extremely preferably 40 to 95 mass %, in the whole monomer components. Because of the ratio of the (A) component within the above range, it becomes easy to control peeling residues and light resistance.
- the ratio of the (B) component used in the acrylic polymer is preferably 0 to 70 mass %, and more preferably 3 to 55 mass %, in the whole monomer components. Because of the ratio of the (B) component within the above range, it becomes easy to control adhesion.
- the ratio of the (C) component used in the acrylic polymer is preferably 0 to 10 mass %, and more preferably 2 to 8 mass % in the whole monomer components. Because of the ratio of the (C) component within the above range, it becomes easy to control peeling residues and the degree of crosslinking due to the reaction with a curing agent.
- the acrylic polymer can be produced, for example, by selecting a known production method, such as solution polymerization, bulk polymerization, emulsion polymerization, or radical polymerization. Further, the obtained acrylic polymer may be any of a random copolymer, a block copolymer, a graft copolymer, and the like.
- the agglutinant layer has moderate cohesive force and adhesive strength, and the agglutinant causes less adhesive residues and has sufficient adhesive strength and load resistance, which is preferable.
- the weight average molecular weight mentioned above is a value measured by gel permeation chromatography (GPC) analysis, and refers to a value in terms of standard polystyrene.
- GPC analysis can be performed using tetrahydrofuran (THF) as an eluent.
- a reaction product of the acrylic polymer and a curing agent is preferably contained as the agglutinant of the agglutinant layer; however, in terms of flexibility, an acrylic polymer that does not react with the curing agent may be contained.
- the curing agent is not particularly limited as long as it is a curing agent that is used as a general agglutinant, and examples thereof include metal salts, metal alkoxides, aldehyde type compounds, non-amino resin type amino compounds, urea type compounds, isocyanate type compounds, polyfunctional epoxy compounds, metal chelate type compounds, melamine type compounds, aziridine type compounds, and the like. Among these, isocyanate type compounds and epoxy compounds are preferable, in terms of the reactivity with the carboxyl group or the hydroxyl group.
- isocyanate type compounds include xylylene diisocyanate, hexamethylene diisocyanate, tolylene diisocyanate, and multimers, derivatives, and polymers thereof, and the like. These may be used singly or in combination of two or more.
- epoxy compounds include compounds having two or more epoxy groups in the molecule, and specific examples thereof include ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, glycerin diglycidyl ether, glycerin triglycidyl ether, 1,6-hexanediol diglycidyl ether, trimethylolpropane triglycidyl ether, diglycidylaniline, diamine glycidylamine, N,N,N′,N′-tetraglycidyl-m-xylylenediamine, 1,3-bis(N,N′-diamineglycidylaminomethyl), and the like. These may be used singly or in combination of two or more.
- the definition of the SP value is as described below.
- the SP value is a solubility parameter.
- the SP value can be determined by the following Equation 1 with reference to the Fedors calculation method [“Polymer Engineering and Science,” Vol. 14, No. 2 (1974), pp. 148-154].
- ⁇ is a solubility parameter (SP value)
- ⁇ ei is molar evaporation energy
- ⁇ vi is molar volume.
- the unit of the solubility parameter is (cal/mol) 1/2 .
- Table 1 shows the eigenvalues of ⁇ ei and ⁇ vi given to the main atoms or atomic groups with respect to the above Equation 1.
- the SP value (solubility parameter) of the acrylic polymer is preferably 10.0 to 12.0, and more preferably 10.0 to 11.0.
- the SP value of the acrylic polymer can be controlled, for example, by changing the concentration of polar groups in the acrylic polymer. For example, when a relatively higher polar bond, such as an ether bond, is introduced into the side chain, the SP value tends to increase. On the other hand, when a relatively less polar bond, such as a long-chain alkylene bond, is introduced into the side chain, the SP value tends to decrease.
- two or more acrylic polymers such as two or more acrylic polymers having different weight average molecular weights, two or more acrylic polymers containing different monomer components, or two or more acrylic polymers with different copolymerization ratios, may be combined as the base material.
- the SP value of only a single acrylic polymer may be within the range, or the SP values of all of the acrylic polymers may be out of the range, but the SP value of the entire acrylic polymer component may be within the range.
- the SP value of the entire acrylic polymer component is calculated by dividing the SP value of each of two or more acrylic polymers proportionally by their respective mixing amounts.
- the shape of the agglutinant layer 14 is preferably a flat shape that is less likely to deform during bonding of the pellicle.
- the agglutinant layer contained a polyvinyl ether compound. Specifically, when mixing was performed so that vinyl ether groups were uniformly dispersed in the whole agglutinant layer, the peeling properties of the agglutinant were further improved, and almost no residues were observed in the visual inspection. Even when the agglutinant layer in which vinyl ether groups were uniformly dispersed was bonded to a mask substrate and then irradiated with 193-nm ultraviolet rays, dust was hardly generated, and the probability of good peeling substantially without leaving peeling residues on the mask substrate was significantly increased.
- the pellicle uses, as a base material that constitutes the mask agglutinant layer, an acrylic polymer having an SP value of 10.0 or more and 12.0 or less, and contains a polyvinyl ether compound, whereby even when an exposure light beam is applied through the mask substrate, surface deterioration is reduced, and fine particulate residues are also reduced when the pellicle is peeled from the mask substrate.
- the regeneration cleaning of the mask substrate, from which the pellicle is peeled proceeds smoothly, the cleaning conditions can be loosened, and there is an advantage in reducing damage to the mask surface during cleaning.
- polyvinyl ether compound examples include homopolymers of vinyl ethers, such as methyl vinyl ether, ethyl vinyl ether, butyl vinyl ether, isobutyl vinyl ether, and (2-methoxyethyl) vinyl ether; copolymers of two or more vinyl ethers; copolymers of these vinyl ethers and other monomers; and the like.
- polyvinyl ether compounds containing methyl vinyl ether as a raw material monomer component are preferable in terms of the control of peeling residues.
- the mixing ratio of an acrylic polymer mentioned above, and the polyvinyl ether compound is, based on mass, 90:10 to 99:1, preferably 92:8 to 98:2, and particularly preferably 94:6 to 96:4, in terms of reducing peeling residues.
- the agglutinant that forms the agglutinant layer of the pellicle may be mixed with other components, such as crosslinking agents, tackifiers, plasticizers, stabilizers, viscosity regulators, antistatic agents, lubricants, conductivity-imparting agents, flame retardancy-imparting agents, thermal conductivity-improving agents, heat resistance-improving agents, weather resistance-improving agents, thixotropy-imparting agents, antioxidants, antimicrobial agents, antifungal agents, and coloring agents, depending on the purpose within the range in which the characteristics of the present invention are not impaired.
- other components such as crosslinking agents, tackifiers, plasticizers, stabilizers, viscosity regulators, antistatic agents, lubricants, conductivity-imparting agents, flame retardancy-imparting agents, thermal conductivity-improving agents, heat resistance-improving agents, weather resistance-improving agents, thixotropy-imparting agents, antioxidants, antimicrobial agents,
- an uncured liquid or paste agglutinant is applied to the lower end face of the pellicle frame 11 , followed by curing treatment, thereby forming an agglutinant layer.
- the agglutinant may be applied once, or may be repeatedly applied several times in order to obtain a predetermined thickness of the agglutinant layer.
- the agglutinant is preferably allowed to stand between each time of coating until the shape of the agglutinant after coating is stabilized.
- the agglutinant may be applied, if necessary, after dilution with an organic solvent, alcohol, water, or the like to reduce the viscosity of the agglutinant.
- the agglutinant can be applied, for example, by dipping, spraying, or brush coating, or by using a coating device with a dispenser or the like. Coating using a coating device with a dispenser is preferable, in terms of stability, workability, yield, and the like.
- the coating and formation of the agglutinant layer 14 are generally performed first, followed by stretching of the pellicle film 12 ; however, the order may be reversed.
- stretching the pellicle film 12 for example, an adhesive material is applied to the upper end face of the pellicle frame 11 , and the pellicle frame 11 is then heated to cure the adhesive material.
- the upper end face of the pellicle frame 11 on which the adhesive material layer 13 for bonding a pellicle film is formed, is bonded to a pellicle film taken in an aluminum frame larger than the pellicle frame 11 , and extra portions of the pellicle film protruding outside the pellicle frame 11 are removed, thereby completing the pellicle.
- the pellicle of the present invention Due to the use of the pellicle of the present invention with the configuration described above, the amount of agglutinant residues can be reduced when the pellicle is peeled from the exposure original plate after being used in lithography. Moreover, the present invention provides a method for reducing peeling residues of the agglutinant layer of the pellicle by using the pellicle of the present invention. Therefore, the pellicle of the present invention is useful as a pellicle bonded to a phase shift photo mask having the delicate phase shift film mentioned above, or a face comprising silicon oxide, such as quartz, as a main component.
- the pellicle of the present invention is also useful as a pellicle applied to exposure original plates whose agglutinant layer is irradiated with an exposure light beam during exposure, such as a negative type exposure original plate, an exposure original plate that has a non-shaded area or a semi-transparent shaded area in a portion thereof to which an agglutinant is bonded, and an exposure original plate that has a transparent area in a portion thereof to which an agglutinant is bonded.
- the agglutinant layer of the pellicle used in such an exposure original plate is exposed to an exposure light beam through the exposure original plate from the face of the exposure original plate opposite to the face provided with the pellicle.
- the pellicle of the present invention may be used not only as a protective member for suppressing the adhesion of foreign substances to the exposure original plate in the exposure device, but also as a protective member for protecting the exposure original plate during storage or transportation of the exposure original plate.
- An exposure original plate with a pellicle can be produced by mounting the pellicle described above on an exposure original plate, such as a photo mask.
- the method for producing a semiconductor device or a liquid crystal display board comprises a step of exposing a substrate (semiconductor wafer or liquid crystal original plate) using the exposure original plate with a pellicle described above.
- a substrate semiconductor wafer or liquid crystal original plate
- the exposure original plate with a pellicle described above is set on a stepper to perform exposure.
- the use of the exposure original plate with a pellicle can improve the yield in the lithography step.
- peeling residues during repellicle can be reduced even in the case of exposure original plates whose agglutinant layer is irradiated with an exposure light beam during exposure, such as an exposure original plate having a face comprising silicon oxide as a main component in which peeling residues of the agglutinant layer are likely to be generated, a negative type exposure original plate whose agglutinant layer is irradiated with an exposure light beam more than before, an exposure original plate that has a non-shaded area or a semi-transparent shaded area in a portion thereof to which an agglutinant is bonded, whose agglutinant layer is irradiated with an exposure light beam more than before, and an exposure original plate that has a transparent area in a portion thereof to which an agglutinant is bonded, whose agglutinant layer is irradiated with an exposure light beam more than before.
- the use of the pellicle of the present invention can reduce peeling residues of the agglutinant layer, cleaning with functional water can be easily applied, and cleaning properties for delicate exposure original plates, such as phase shift photo masks, can be improved.
- the use of the pellicle of the present invention can contribute to the reduction of environmental burden caused by cleaning with functional water.
- a pellicle frame (external size: 149 mm ⁇ 115 mm ⁇ 3.5 mm, thickness: 2 mm, flatness of an end face coated with a mask bonding agglutinant: 15 um) made of an aluminum alloy was subjected to precision cleaning, an acrylic agglutinant manufactured by Soken Chemical Co., Ltd. (product name: SK-Dyne SN-70A, containing, as a base material, an acrylic polymer in which 95 mass % of monomer components was an ethylene oxide group-containing (meth)acrylate; SP value of the base material: 10.2) was applied to the end face with a flatness of 15 um, and allowed to stand for 60 minutes at room temperature.
- an acrylic agglutinant manufactured by Soken Chemical Co., Ltd. product name: SK-Dyne SN-70A, containing, as a base material, an acrylic polymer in which 95 mass % of monomer components was an ethylene oxide group-containing (meth)acrylate; SP value of the
- a separator was placed on an aluminum plate with a flatness of 5 um, and the pellicle frame coated with the agglutinant was placed so that the agglutinant faced down. Thus, the agglutinant was brought into contact with the flat separator and flattened.
- the pellicle on the aluminum plate was placed in an oven at 60° C. for 60 minutes to cure the agglutinant.
- an adhesive material manufactured by AGC Inc. (trade name: Cytop CTX-A) was applied to the end face opposite to the end face coated with the agglutinant. Then, the pellicle frame was heated at 130° C. to cure the adhesive material.
- the adhesive material-coated end face of the pellicle frame was bonded to a pellicle film taken in an aluminum flame larger than the pellicle frame, and portions outside the pellicle frame were removed, thereby completing the pellicle.
- a 6025 mask substrate (6 inch) and the previously prepared pellicle were set in a bonding device, and pressurized at a bonding load of 50 N for a load time of 30 seconds to bond the pellicle to the mask substrate.
- the back surface of the mask was irradiated with ultraviolet rays at 10 mJ/cm 2 using a 193-nm ultraviolet lamp so that the light beam was applied to the pellicle agglutinant.
- the resultant was left for 1 hour at room temperature, and then the pellicle was slowly peeled upward from the mask substrate at a speed of 0.1 mm/sec.
- a pellicle was completed in the same manner using the same materials as in Example 1, except that the agglutinant used herein was an acrylic agglutinant manufactured by Soken Chemical Co., Ltd. (product name: SN-25B, containing, as a base material, an acrylic polymer in which 40 mass % of monomer components was an ethylene oxide group-containing (meth)acrylate; SP value of the base material: 10.5). Further, the pellicle was bonded to and peeled from a mask substrate under the same conditions as in Example 1.
- a pellicle was completed in the same manner using the same materials as in Example 1, except that the agglutinant used herein contained 3 mass parts of a polyvinyl ether compound based on 100 mass parts of SK-Dyne SN-70A. Further, the pellicle was bonded to and peeled from a mask substrate under the same conditions as in Example 1.
- a pellicle was completed in the same manner using the same materials as in Example 1, except that the agglutinant used herein was an acrylic agglutinant manufactured by Soken Chemical Co., Ltd. (product name: SK-Dyne SK-1425S, containing, as a base material, an acrylic polymer not containing a (meth)acrylic acid ester having an ether bond as a monomer component; SP value of the base material: 9.8). Further, the pellicle was bonded to and peeled from a mask substrate under the same conditions as in Example 1.
- the agglutinant used herein was an acrylic agglutinant manufactured by Soken Chemical Co., Ltd. (product name: SK-Dyne SK-1425S, containing, as a base material, an acrylic polymer not containing a (meth)acrylic acid ester having an ether bond as a monomer component; SP value of the base material: 9.8).
- the pellicle was bonded to and pe
- a pellicle was completed in the same manner using the same materials as in Example 1, except that the agglutinant used herein was an acrylic agglutinant manufactured by Soken Chemical Co., Ltd. (product name: SK-Dyne SK-1495S, containing, as a base material, an acrylic polymer not containing a (meth)acrylic acid ester having an ether bond as a monomer component; SP value of the base material: 9.2). Further, the pellicle was bonded to and peeled from a mask substrate under the same conditions as in Example 1.
- the agglutinant used herein was an acrylic agglutinant manufactured by Soken Chemical Co., Ltd. (product name: SK-Dyne SK-1495S, containing, as a base material, an acrylic polymer not containing a (meth)acrylic acid ester having an ether bond as a monomer component; SP value of the base material: 9.2).
- the pellicle was bonded to and peeled
- a 5-L flask equipped with a stirrer, a reflux condenser, a thermometer, and a gas inlet was charged with 320 g of butyl acrylate, 550 g of 2-methoxyethyl acrylate, 80 g of acrylic acid, 50 g of 2-hydroxyethyl acrylate, 1500 g of ethyl acetate, and 2 g of azobisisobutyronitrile as a polymerization initiator. Solution polymerization was carried out at 68° C. for 8 hours in a nitrogen gas stream.
- a 5-L flask equipped with a stirrer, a reflux condenser, a thermometer, and a gas inlet was charged with 400 g of 2-ethylhexyl acrylate, 500 g of 2-ethoxyethyl acrylate, 100 g of acrylic acid, 1200 g of ethyl acetate, and 2 g of azobisisobutyronitrile as a polymerization initiator.
- Solution polymerization was carried out at 68° C. for 8 hours in a nitrogen gas stream. After the completion of the reaction, 1130 g of ethyl acetate was added thereto, thereby obtaining a solution of an acrylic polymer with a solid content of 30% (SP value: 10.1).
- a polyisocyanate solution was added to the obtained acrylic polymer solution, and the mixture was stirred and mixed to obtain an agglutinant.
- a 5-L flask equipped with a stirrer, a reflux condenser, a thermometer, and a gas inlet was charged with 350 g of 2-ethylhexyl acrylate, 550 g of 2-methoxyethyl acrylate, 50 g of methacrylic acid, 50 g of 2-hydroxyethyl methacrylate, 1400 g of ethyl acetate, and 2 g of azobisisobutyronitrile as a polymerization initiator.
- Solution polymerization was carried out at 68° C. for 8 hours in a nitrogen gas stream.
- a 5-L flask equipped with a stirrer, a reflux condenser, a thermometer, and a gas inlet was charged with 300 g of butyl acrylate, 550 g of 2-methoxyethyl acrylate, 100 g of 2-hydroxybutyl acrylate, 50 g of itaconic acid, 1500 g of ethyl acetate, and 2 g of azobisisobutyronitrile as a polymerization initiator. Solution polymerization was carried out at 68° C. for 8 hours in a nitrogen gas stream.
- a 5-L flask equipped with a stirrer, a reflux condenser, a thermometer, and a gas inlet was charged with 300 g of butyl acrylate, 600 g of methoxypolyethylene glycol acrylate, 100 g of acrylic acid, 1400 g of ethyl acetate, and 2 g of azobisisobutyronitrile as a polymerization initiator.
- Solution polymerization was carried out at 68° C. for 8 hours in a nitrogen gas stream. After the completion of the reaction, 930 g of ethyl acetate was added thereto, thereby obtaining a solution of an acrylic polymer with a solid content of 30% (SP value: about 10).
- a polyisocyanate solution was added to the obtained acrylic polymer solution, and the mixture was stirred and mixed to obtain an agglutinant.
- Pellicles were produced in the same manner as in Example 1, except that the agglutinant used herein was each of the agglutinants obtained in Synthesis Examples 1 to 5, and a peeling test was performed. As a result, the pellicles using any of the agglutinants resulted in reduced peeling residues and had improved cleaning removing properties, compared with the Comparative Examples.
Landscapes
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Manufacturing & Machinery (AREA)
- Computer Hardware Design (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Power Engineering (AREA)
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Environmental & Geological Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Preparing Plates And Mask In Photomechanical Process (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Exposure And Positioning Against Photoresist Photosensitive Materials (AREA)
- Adhesive Tapes (AREA)
- Container, Conveyance, Adherence, Positioning, Of Wafer (AREA)
- Liquid Crystal (AREA)
Abstract
Provided is an agglutinant for pellicles that can reduce residues stuck onto an exposure original plate when a pellicle is peeled from the exposure original plate after being used in lithography, in particular ArF lithography, and also provided are a pellicle, an exposure original plate with a pellicle, a method for regenerating an exposure original plate, and a peeling residue reduction method.An agglutinant for pellicles for bonding a pellicle to an exposure original plate, in which the agglutinant includes an acrylic polymer having an SP value of 10.0 or more and 12.0 or less as a base material.
Description
- The present invention relates to an agglutinant for pellicles, a pellicle, an exposure original plate with a pellicle, a method for producing a semiconductor device, a method for producing a liquid crystal display board, a method for regenerating an exposure original plate, and a peeling residue reduction method.
- In manufacturing semiconductor devices such as LSI and super-LSI or in manufacturing a liquid crystal display board or the like, a pattern is made by irradiating light to a semiconductor wafer or an original plate for liquid crystal, but if dust is attached to an exposure original plate used in this case, the dust absorbs the light or bends the light. As a result, the transferred pattern would be deformed, and the resulting pattern would have roughened edges or black stains on the base, which would lead to problems such as damaged dimensions, poor quality, and deformed external appearance. In the present invention, the “exposure original plate” is a generic name of lithography masks and reticles.
- These works are usually performed in a cleanroom, but it is difficult to keep the exposure original plate clean all the time even in the cleanroom. Therefore, a pellicle that transmits light for exposure well is bonded to a surface of the exposure original plate as a dust-fender.
- Under such circumstances, the dust does not directly adhere to the surface of the exposure original plate but adhere only to the pellicle film. Accordingly, when the focus is set on the pattern of the exposure original plate during lithography, the dust on the pellicle film becomes irrelevant to transfer.
- The basic structure of the pellicle comprises a pellicle frame and a pellicle film stretched over the pellicle frame. The pellicle film is made of nitrocellulose, cellulose acetate, a fluorine-based polymer, or the like that well transmits light used for exposure (g-rays, i-rays, 248 nm, 193 nm, 157 nm, etc.). The pellicle frame is made of an aluminum alloy such as A7075, A6061, or A5052 treated with black alumite or the like, stainless steel, polyethylene, or the like. A good solvent of a pellicle film is applied to the upper part of the pellicle frame, and the pellicle film is bonded by air-drying or using an adhesive material such as an acrylic resin, an epoxy resin, or fluororesin. Further, since the lower part of the pellicle frame is mounted with an exposure original plate, an agglutinant layer obtained from a polybutene resin, a polyvinyl acetate resin, an acrylic resin, a silicone resin, or the like, and a protective liner for protecting the agglutinant layer are provided.
- The pellicle is provided so as to surround a pattern region formed on the surface of the exposure original plate. Since the pellicle is provided to prevent the adhesion of dust to the exposure original plate, the pattern region and the outside of the pellicle are isolated from each other so that dust from the outside of the pellicle does not adhere to the pattern surface.
- In recent years, miniaturization of LSI design rules to sub-quarter microns has progressed. Along with this, the wavelength of exposure light sources is becoming shorter. That is, the trend is moving from g-rays (436 nm) and i-rays (365 nm) produced by mercury lamps, which have been the mainstream until now, to KrF excimer laser (248 nm), ArF excimer laser (193 nm), F2 laser (157 nm), and the like. As a result of progress in miniaturization, the allowable size of foreign substances and haze that may be generated on the pattern face of the mask substrate to which the pellicle is bonded is becoming more and more strict.
-
- IP Publication 1: Japanese Patent No. 5638693
- IP Publication 2: Japanese Patent Application Publication No. 2016-18008
- IP Publication 3: Japanese Patent Application Publication No. 2006-146085
- IP Publication 4: Japanese Patent Application Publication No. 2008-21182
- In recent years, phase shift films have been commonly used as mask substrate films to meet the miniaturization of design rules. However, phase shift films are very delicate, and mask cleaning under excessive conditions may cause damage, such as corrosion and scraping, to the phase shift films. For this reason, in recent years, there has been a tendency to reconsider chemicals used for mask cleaning, and to weaken the cleaning conditions.
- Furthermore, the mask pattern of advanced mask products is shifting from positive type mask patterns, which have been the mainstream until now, to negative type mask patterns. As a result, there are many situations where no light-shading layer is provided in the portion to which the pellicle is bonded. If there is no light-shading layer, there is a possibility that the pellicle agglutinant is irradiated with an exposure light beam through the mask substrate. In that case, more residues of the agglutinant layer may remain on the mask substrate when the pellicle is peeled.
- During use of a pellicle bonded to a mask, if foreign substances and haze are generated, or if the pellicle film is damaged, it is necessary to peel the pellicle, subject the mask to regeneration cleaning, and bond a new pellicle (which is hereinafter referred to as “repellicle”). It is the most important for repellicle that regeneration cleaning is performed so that the mask is kept in a state of high cleanliness; however, in order to carry out regeneration cleaning of the mask under recent weak cleaning conditions, it is important to reduce residues remaining on the mask substrate when the pellicle is peeled.
- As regeneration cleaning, cleaning with chemicals such as sulfuric acid hydrogen peroxide or ammonia hydrogen peroxide, and physical cleaning by brushes, sponges, or the like are generally used. However, regeneration cleaning with functional water is being studied to prevent damage to photo masks and sulfate ions from remaining on the photo masks.
- Functional water is generally defined by the Japanese Society for Functional Water as, among aqueous solutions that have been given reproducible and useful functions by artificial treatment, those for which the scientific basis for treatment and function has been clarified, and those for which such scientific basis is about to be clarified. Specific examples thereof include fine bubble water such as ozone water, hydrogen water, micro-bubble water, and nano-bubble water; electrolyzed water, supercritical water, subcritical water, and the like. Ozone water and hydrogen water are often used to clean photo masks. In addition, the cleaning power can be improved by adding a small amount of ammonia.
- However, the present inventors found that since the cleaning power of functional water was weaker than that of chemicals such as sulfuric acid hydrogen peroxide, in the regeneration cleaning of the photo mask after the removal of the pellicle, residues of the agglutinant layer that fixed the pellicle and the photo mask were difficult to remove only by functional water cleaning. In particular, in phase shift photo masks, damage to phase shift films leads to changes in transmittance and phase difference, and it is thus difficult to add physical cleaning in addition to functional water cleaning.
- Moreover, when lithography is performed using an exposure light beam such as ArF excimer laser (193 nm) on a lithography pellicle in which a pellicle film is stretched over the upper end face of a pellicle frame through a pellicle film bonding adhesive material layer, and in which a mask bonding agglutinant layer is provided on the other end face, there is a problem that the agglutinant layer formed on the lower end face of the pellicle frame is altered by the exposure light beam, and many altered parts of the agglutinant layer remain on the exposure original plate as peeling residues when peeling from the exposure original plate.
- Attempts have been made so far to reduce residues by adding surface modifiers or the like to agglutinants (IP
Publications 1 and 2 described above). Further, as techniques of reducing residues, a large pellicle having an agglutinant layer with a cohesive fracture strength of 20 g/mm2 or more (IP Publication 3 described above), and a pellicle comprising an agglutinant for pellicles and having a ratio of peeling strength and tensile strength of 0.10 or more and 0.33 or less are disclosed (IP Publication 4 described above). - The present invention was made in view of such circumstances, and an object of the present invention is to provide an agglutinant for pellicles that can reduce residues stuck onto an exposure original plate when a pellicle is peeled from the exposure original plate after being used in lithography, in particular ArF lithography, and to also provide a pellicle, an exposure original plate with a pellicle, a method for regenerating an exposure original plate, and a peeling residue reduction method. Another object of the present invention is to provide a method for producing a semiconductor device and a method for producing a liquid crystal display board that can thereby improve production efficiency.
- [1] An agglutinant for pellicles for bonding a pellicle to an exposure original plate, the agglutinant comprising an acrylic polymer having an SP value of 10.0 or more and 12.0 or less as a base material.
- [2] An agglutinant for pellicles for bonding a pellicle to an exposure original plate, the agglutinant comprising an acrylic polymer as a base material, the acrylic polymer comprising a (meth)acrylic acid ester having an ether bond as a monomer component.
- [3] An agglutinant for pellicles as claimed in [2] described above, wherein the (meth)acrylic acid ester having an ether bond is a (meth)acrylic acid ester having an alkylene oxide group.
- [4] An agglutinant for pellicles as claimed in [3] described above, wherein the (meth)acrylic acid ester having an ether bond is contained in an amount of 30 mass % or more based on the whole monomer components.
- [5] An agglutinant for pellicles as claimed in [3] or [4] described above, wherein the alkylene oxide group is an ethylene oxide group.
- [6] An agglutinant for pellicles as claimed in any one of [2] to [5] described above, further comprising an unsaturated monomer having a carboxyl group or a hydroxyl group as a monomer component.
- [7] An agglutinant for pellicles as claimed in any one of [2] to [6] described above, further comprising a (meth)acrylic acid alkyl ester as a monomer component.
- [8] An agglutinant for pellicles for bonding a pellicle to an exposure original plate, the agglutinant comprising an acrylic polymer as a base material, the acrylic polymer having a side chain containing an ether bond.
- [9] An agglutinant for pellicles as claimed in [8] described above, wherein the side chain containing an ether bond has an alkylene oxide group.
- [10] An agglutinant for pellicles as claimed in [9] described above, wherein the alkylene oxide group is an ethylene oxide group.
- [11] An agglutinant for pellicles for bonding a pellicle to an exposure original plate, the agglutinant comprising an acrylic polymer as a base material, the acrylic polymer having a side chain that has higher degradability by irradiation with an exposure light beam than a main chain.
- [12] An agglutinant for pellicles for bonding a pellicle to an exposure original plate, the agglutinant comprising an acrylic polymer as a base material, the acrylic polymer having a side chain that is selectively degraded by irradiation with an exposure light beam.
- [13] A pellicle frame with an agglutinant layer, comprising a pellicle frame and an agglutinant layer provided on one end face of the pellicle frame and obtained from an agglutinant for pellicles as claimed in any one of [1] to [12] described above.
- [14] A pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film on one end face thereof, and an agglutinant layer provided on the other end face of the pellicle frame and obtained from an agglutinant for pellicles as claimed in any one of [1] to [12] described above.
- [15] A pellicle as claimed in [14] described above, wherein the agglutinant layer is irradiated with an exposure light beam.
- [16] A pellicle as claimed in [14] described above, wherein the pellicle is bonded to a phase shift photo mask.
- [17] A pellicle as claimed in [14] described above, wherein the pellicle is bonded to a negative type exposure original plate.
- [18] A pellicle as claimed in [14] described above, wherein the pellicle is bonded to an exposure original plate that has a non-shaded area or a semi-transparent shaded area in a portion thereof to which an agglutinant layer is bonded.
- [19] A pellicle as claimed in [14] described above, wherein the pellicle is bonded to an exposure original plate that has a transparent area in a portion thereof to which an agglutinant layer is bonded.
- [20] A pellicle as claimed in [14] described above, wherein the pellicle is bonded to a face comprising silicon oxide as a main component.
- [21] A pellicle as claimed in [20] described above, wherein the face comprising silicon oxide as a main component is a quartz face.
- [22] A pellicle as claimed in [14] described above, wherein the pellicle is compatible with regeneration cleaning with functional water.
- [23] An exposure original plate with a pellicle, comprising an exposure original plate and a pellicle as claimed in [14] or [15] described above mounted on the exposure original plate.
- [24] An exposure original plate with a pellicle as claimed in [23] described above, wherein the exposure original plate is a phase shift photo mask.
- [25] An exposure original plate with a pellicle as claimed in [23] described above, wherein the exposure original plate is of negative type.
- [26] An exposure original plate with a pellicle as claimed in [23] described above, wherein a portion of the exposure original plate to which the agglutinant layer is bonded has a non-shaded area or a semi-transparent shaded area.
- [27] An exposure original plate with a pellicle as claimed in [23] described above, wherein a portion of the exposure original plate to which the agglutinant layer is bonded has a transparent area.
- [28] An exposure original plate with a pellicle as claimed in [23] described above, wherein the exposure original plate comprises silicon oxide as a main component.
- [29] An exposure original plate with a pellicle as claimed in [23] described above, wherein the exposure original plate is a quartz substrate.
- [30] A method for producing a semiconductor device, comprising a step of performing exposure using an exposure original plate with a pellicle as claimed in any one of [23] to [29] described above.
- [31] A method for producing a liquid crystal display board, comprising a step of performing exposure using an exposure original plate with a pellicle as claimed in any one of [23] to [29] described above.
- [32] A method for regenerating an exposure original plate, comprising peeling a pellicle from an exposure original plate with a pellicle as claimed in any one of [23] to [29] described above, and cleaning residues of an agglutinant remaining on the exposure original plate with functional water to regenerate the exposure original plate.
- [33] A peeling residue reduction method comprising, when peeling a pellicle from an exposure original plate to which the pellicle is bonded, reducing peeling residues of an agglutinant layer of the pellicle remaining on the exposure original plate, wherein the method uses a pellicle as claimed in any one of [14] to [22] described above as the pellicle.
- [34] An application of a pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film on one end face thereof, and an agglutinant layer provided on the other end face of the pellicle frame and obtained from an agglutinant for the pellicle, wherein the agglutinant layer is irradiated with an exposure light beam.
- [35] An application of a pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film on one end face thereof, and an agglutinant layer provided on the other end face of the pellicle frame and obtained from an agglutinant for the pellicle, wherein the pellicle is bonded to a phase shift photo mask.
- [36] An application of a pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film on one end face thereof, and an agglutinant layer provided on the other end face of the pellicle frame and obtained from an agglutinant for the pellicle, wherein the pellicle is bonded to a negative type exposure original plate.
- [37] An application of a pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film on one end face thereof, and an agglutinant layer provided on the other end face of the pellicle frame and obtained from an agglutinant for the pellicle, wherein the pellicle is bonded to an exposure original plate that has a non-shaded area or a semi-transparent shaded area in a portion thereof to which the agglutinant layer is bonded.
- [38] An application of a pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film on one end face thereof, and an agglutinant layer provided on the other end face of the pellicle frame and obtained from an agglutinant for the pellicle, wherein the pellicle is bonded to an exposure original plate that has a transparent area in a portion thereof to which the agglutinant layer is bonded.
- [39] An application of a pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film on one end face thereof, and an agglutinant layer provided on the other end face of the pellicle frame and obtained from an agglutinant for the pellicle, wherein the pellicle is bonded to a face comprising silicon oxide as a main component (in particular, a quartz face).
- [40] An application of a pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film on one end face thereof, and an agglutinant layer provided on the other end face of the pellicle frame and obtained from an agglutinant for the pellicle, wherein the pellicle is compatible with regeneration cleaning with functional water.
- [41] A peeling residue reduction pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film bonded to one end face thereof, and an agglutinant layer for bonding the pellicle provided on the other end face of the pellicle frame to an exposure original plate, wherein the agglutinant layer comprises an acrylic resin having an SP value of 10.0 or more and 12.0 or less as a base material.
- [42] A peeling residue reduction pellicle as claimed in [41] described above, wherein the agglutinant layer further contains a polyvinyl ether compound.
- [43] A peeling residue reduction pellicle as claimed in [41] or [42] described above, wherein the peeling residue reduction pellicle is a peeling residue reduction pellicle for ArF lithography.
- [44] A method for producing a peeling residue reduction pellicle, the method comprising selecting an agglutinant for bonding the pellicle to an exposure original plate, applying the agglutinant to one end face of a pellicle frame to form an agglutinant layer, peelably bonding a protective member thereto, applying an adhesive material to the other end face of the pellicle frame, and bonding a pellicle film thereto, wherein in selection of the agglutinant, one comprising an acrylic resin having an SP value of 10.0 or more and 12.0 or less as a base material is selected.
- [45] A method for producing a peeling residue reduction pellicle as claimed in [44] described above, wherein the agglutinant layer further contains a polyvinyl ether compound.
- [46] A method for reducing, when a pellicle is peeled from an exposure original plate to which the pellicle is bonded, peeling residues of an agglutinant layer of the pellicle remaining on the exposure original plate, wherein the method uses a pellicle as claimed in any one of [41] to [43] described above as the pellicle.
- The present invention can provide a pellicle that can reduce peeling residues stuck onto an exposure original plate when a pellicle is peeled from the exposure original plate after being used in lithography, in particular ArF lithography, and can also provide an exposure original plate with a pellicle, a method for regenerating an exposure original plate, and a peeling residue reduction method. According to the pellicle, exposure original plate with a pellicle, method for regenerating an exposure original plate, and peeling residue reduction method of the present invention, even when an exposure light beam is applied through the exposure original plate, the pellicle can be peeled from the exposure original plate with very few peeling residues of the agglutinant. As a result, the regeneration cleaning of the exposure original plate, from which the pellicle is removed, can proceed smoothly, and the cleaning conditions can be loosened; thus, there is an advantage in reducing damage to the exposure original plate surface during cleaning. In addition, production efficiency can be improved in the production of semiconductor devices and liquid crystal display boards.
- In the pellicle of the present invention, it is assumed that since a specific acrylic polymer (also referred to as an acrylic resin) is used as the base material of the agglutinant, the intermolecular force inside the agglutinant is improved, appropriate adhesive strength can be maintained, and not only large residues but also particulate residues are reduced during peeling from the exposure original plate.
-
FIG. 1 A conceptual diagram showing the basic structure of the pellicle of the present invention. - First, the basic structure of the pellicle of the present invention will be described with reference to
FIG. 1 . - As shown in
FIG. 1 , thepellicle 10 of the present invention is such that apellicle film 12 is stretched over the upper end face of apellicle frame 11 through anadhesive material layer 13 for bonding the pellicle film. In this case, anagglutinant layer 14 for bonding thepellicle 10 to an exposure original plate (mask substrate or reticle) 1 is generally formed on the lower end face of thepellicle frame 11, and a liner (not shown) is peelably bonded to the lower end face of theagglutinant layer 14. In addition, thepellicle frame 11 may be provided with an air pressure adjustment hole (vent) 15, and may be further provided with adust removal filter 16 for the purpose of removing particles. - In this case, the size of these pellicle constituent members is equivalent to that of general pellicles, for example, pellicles for semiconductor lithography and pellicles for the lithography step in the production of large liquid crystal display boards. Moreover, the materials thereof can be known materials as described above.
- The type of
pellicle film 12 is not particularly limited. For example, amorphous fluoropolymers conventionally used for excimer laser are used. Examples of amorphous fluoropolymers include Cytop (trade name of AGC Inc.), Teflon (registered trademark) AF (trade name of DuPont), and the like. These polymers may be used after being dissolved in solvents, if necessary, during the production of pellicle films, and can be suitably dissolved, for example, in fluorine type solvents. - As for the base material of the
pellicle frame 11, for example, aluminum alloy materials, preferably JIS A7075, JIS A6061, and JIS A5052 materials, are used. When an aluminum alloy material is used, there is no particular limitation as long as the strength as the pellicle frame is ensured. The pellicle frame surface is preferably roughened by sandblasting or chemical polishing, and a polymer coating may be provided after roughening. In the present invention, a conventionally known method can be employed as the method for roughening the frame surface. In a preferable method, the surface of an aluminum alloy material is subjected to blast treatment using stainless steel, carborundum, glass beads, or the like, and is further subjected to chemical polishing using NaOH or the like, thereby roughening the surface. - By the way, the present inventors conducted many discussions and experiments in order to solve the above problems of the present invention, particularly focused on the feature of the agglutinant forming the agglutinant layer, and comparatively analyzed the experimental results. As a result, the present inventors found that the following means was effective.
- That is, a first aspect of the agglutinant for pellicles of the present invention is to use an acrylic polymer having an SP value of 10.0 or more and 12.0 or less as a base material. Due to the acrylic polymer having an SP value of 10.0 or more and 12.0 or less, when the pellicle is peeled from the exposure original plate, peeling residues of the agglutinant layer remaining on the exposure original plate can be reduced. When the SP value is 10.0 or more, residues that can hardly be removed by cleaning can be reduced. On the other hand, when the SP value is 12.0 or less, the volatility of the agglutinant can be reduced, which leads to the suppression of haze. The present inventors assume that the effects of the present invention can be obtained by improving the hydrophilicity of the acrylic polymer by setting the SP value within the specific range.
- A second aspect of the agglutinant for pellicles of the present invention is to use, as a base material, an acrylic polymer comprising a (meth)acrylic acid ester having an ether bond as a monomer component. Because a (meth)acrylic acid ester having an ether bond is contained as a monomer component of an acrylic polymer, when the pellicle is peeled from the exposure original plate, peeling residues of the agglutinant layer remaining on the exposure original plate can be reduced. Due to the introduction of an ether bond into an acrylic polymer, it becomes easy to control the hydrophilicity of the acrylic polymer. In addition, due to the introduction of an ether bond into the side chain of an acrylic polymer, the ether bond is assumed to prevent light-deterioration of the main chain.
- A third aspect of the agglutinant for pellicles of the present invention is to use, as a base material, an acrylic polymer having a side chain containing an ether bond. Because an ether bond is contained in the side chain of an acrylic polymer, when the pellicle is peeled from the exposure original plate, peeling residues of the agglutinant layer remaining on the exposure original plate can be reduced. Due to the introduction of an ether bond into an acrylic polymer, it becomes easy to control the hydrophilicity of the acrylic polymer. In addition, the introduction of an ether bond into the side chain of an acrylic polymer is assumed to prevent light-deterioration of the main chain.
- A fourth aspect of the agglutinant for pellicles of the present invention is to use, as a base material, an acrylic polymer having a side chain that has higher degradability by irradiation with an exposure light beam than a main chain. Because the degradability of the side chain of the acrylic polymer by irradiation with an exposure light beam is higher than that of the main chain, when the pellicle is peeled from the exposure original plate, peeling residues of the agglutinant layer remaining on the exposure original plate can be reduced. It is assumed that since the degradability of the side chain by the exposure light beam is higher than that of the main chain, the degradation of the side chain substantially precedes the degradation of the main chain, and peeling residues can be reduced. The degradation of the side chain has less effect on the deterioration of the agglutinant, and even if the degradation proceeds, it is considered that the agglutinant is less likely to remain as peeling residues during peeling due to the cohesive force of the agglutinant. On the other hand, if the light-deterioration of the main chain proceeds, the molecular weight of the main chain is reduced, and it is considered that the reduced-molecular-weight agglutinant remains on the substrate as residues. Here, the difference in degradability can be determined, for example, by comparing the decomposition product of the main chain and the decomposition product of the side chain before and after irradiation of the agglutinant with an exposure light beam by IR, NMR, or the like. More specifically, it can be confirmed by comparing the IR chart of the agglutinant before irradiation with an exposure light beam with the IR chart of the agglutinant after irradiation with an exposure light beam, and observing the change in spectral intensity. Examples of the wave number to be confirmed include C—O—C (methoxy group) at 1125 cm−1, C—O—C (ether group) at 1160 cm−1, C═O (ester group) at 1727 cm−1, and the like.
- A fifth aspect of the agglutinant for pellicles of the present invention is to use, as a base material, an acrylic polymer having a side chain that is selectively deteriorated by irradiation with an exposure light beam. Because the side chain of the acrylic polymer is selectively deteriorated by irradiation with an exposure light beam, when the pellicle is peeled from the exposure original plate, peeling residues of the agglutinant layer remaining on the exposure original plate can be reduced. It is assumed that since the side chain is selectively deteriorated by irradiation with an exposure light beam, the degradation of the side chain substantially precedes the degradation of the main chain, and peeling residues can be reduced. The degradation of the side chain has relatively less effect on the deterioration of the agglutinant, and even if the degradation proceeds, it is considered that the agglutinant is less likely to remain as peeling residues during peeling due to the cohesive force of the agglutinant. On the other hand, if the light-deterioration of the main chain proceeds, the molecular weight of the main chain is reduced, and it is considered that the reduced-molecular-weight agglutinant remains on the substrate as residues. Here, the presence of deterioration can be determined, for example, by comparing the decomposition product of the main chain and the decomposition product of the side chain before and after irradiation of the agglutinant with an exposure light beam by IR, NMR, or the like. More specifically, it can be confirmed by comparing the IR chart of the agglutinant before irradiation with an exposure light beam with the IR chart of the agglutinant after irradiation with an exposure light beam, and observing the change in spectral intensity. Examples of the wave number to be confirmed include C—O—C (methoxy group) at 1125 cm−1, C—O—C (ether group) at 1160 cm−1, C═O (ester group) at 1727 cm−1, and the like.
- In the present invention, the “agglutinant comprising an acrylic polymer as a base material” refers to an agglutinant containing an acrylic polymer itself or an agglutinant containing a reaction product of the acrylic polymer, a curing agent, and the like.
- The present inventors found that in a pellicle provided with an agglutinant layer obtained from such an agglutinant, the agglutinant layer suppressed deterioration due to an exposure light beam, and that even if deterioration occurred, peeling residues were less likely to be generated during peeling from the mask substrate (exposure original plate).
- In the present invention, the acrylic polymer mentioned above is, for example, a polymer comprising a (meth)acrylic acid ester as a monomer component, and a monomer component copolymerizable with the (meth)acrylic acid ester can be copolymerized, if necessary. Examples of the (meth)acrylic acid ester include (meth)acrylic acid esters having an ether bond, (meth)acrylic acid alkyl esters, unsaturated monomers having a carboxyl group or a hydroxyl group, and the like. When a (meth)acrylic acid ester having an ether bond is contained as a monomer component, the ether bond can be introduced into the side chain of the acrylic polymer.
- Examples of the (meth)acrylic acid ester having an ether bond ((A) component) include (meth)acrylic acid esters having an alkylene oxide group, such as an ethylene oxide group, a propylene oxide group, or a butylene oxide group. Among these, (meth)acrylic acid esters having an ethylene oxide group (also referred to as ethylene oxide group-containing (meth)acrylates) are preferable. Examples thereof include methoxypolyethylene glycol (meth)acrylates, such as 2-methoxyethyl (meth)acrylate, 2-ethoxyethyl (meth)acrylate, 2-butoxyethyl (meth)acrylate, phenoxyethylene glycol (meth)acrylate, and methoxydiethylene glycol (meth)acrylate; ethoxypolyethylene glycol (meth)acrylates, such as ethoxydiethylene glycol (meth)acrylate; butoxypolyethylene glycol (meth)acrylates, such as butoxydiethylene glycol (meth)acrylate; phenoxypolyethylene glycol (meth)acrylates, such as phenoxydiethylene glycol (meth)acrylate; and the like. These may be used singly or in combination of two or more.
- Examples of the (meth)acrylic acid alkyl ester ((B) component) include (meth)acrylic acid alkyl esters having a C1-14 alkyl group, and the like. Specific examples thereof include methyl (meth)acrylate, ethyl (meth)acrylate, propyl (meth)acrylate, n-butyl (meth)acrylate, isobutyl (meth)acrylate, isoamyl (meth)acrylate, hexyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, n-octyl (meth)acrylate, isooctyl (meth)acrylate, isononyl (meth)acrylate, lauryl (meth)acrylate, and the like. Among these, (meth)acrylic acid alkyl esters having a C4 or C8 alkyl group are preferable, in terms of satisfying both agglutinant characteristics and peeling characteristics. These may be used singly or in combination of two or more.
- Examples of the unsaturated monomer having a carboxyl group or a hydroxyl group ((C) component) include α,β-unsaturated carboxylic acids, such as (meth)acrylic acid, maleic acid, crotonic acid, itaconic acid, and fumaric acid; hydroxyl group-containing methacrylates, such as 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, and 2-hydroxybutyl (meth)acrylate; and the like. These may be used singly or in combination of two or more.
- The ratio of the (A) component used in the acrylic polymer is preferably 30 mass % or more, more preferably 35 mass % or more, particularly preferably 35 to 98 mass %, and extremely preferably 40 to 95 mass %, in the whole monomer components. Because of the ratio of the (A) component within the above range, it becomes easy to control peeling residues and light resistance.
- The ratio of the (B) component used in the acrylic polymer is preferably 0 to 70 mass %, and more preferably 3 to 55 mass %, in the whole monomer components. Because of the ratio of the (B) component within the above range, it becomes easy to control adhesion.
- The ratio of the (C) component used in the acrylic polymer is preferably 0 to 10 mass %, and more preferably 2 to 8 mass % in the whole monomer components. Because of the ratio of the (C) component within the above range, it becomes easy to control peeling residues and the degree of crosslinking due to the reaction with a curing agent.
- The acrylic polymer can be produced, for example, by selecting a known production method, such as solution polymerization, bulk polymerization, emulsion polymerization, or radical polymerization. Further, the obtained acrylic polymer may be any of a random copolymer, a block copolymer, a graft copolymer, and the like.
- When the molecular weight of the acrylic polymer is within the range of 700,000 to 2.5 million as weight average molecular weight, the agglutinant layer has moderate cohesive force and adhesive strength, and the agglutinant causes less adhesive residues and has sufficient adhesive strength and load resistance, which is preferable.
- The weight average molecular weight mentioned above is a value measured by gel permeation chromatography (GPC) analysis, and refers to a value in terms of standard polystyrene. The GPC analysis can be performed using tetrahydrofuran (THF) as an eluent.
- In the present embodiment, a reaction product of the acrylic polymer and a curing agent is preferably contained as the agglutinant of the agglutinant layer; however, in terms of flexibility, an acrylic polymer that does not react with the curing agent may be contained.
- The curing agent is not particularly limited as long as it is a curing agent that is used as a general agglutinant, and examples thereof include metal salts, metal alkoxides, aldehyde type compounds, non-amino resin type amino compounds, urea type compounds, isocyanate type compounds, polyfunctional epoxy compounds, metal chelate type compounds, melamine type compounds, aziridine type compounds, and the like. Among these, isocyanate type compounds and epoxy compounds are preferable, in terms of the reactivity with the carboxyl group or the hydroxyl group.
- Examples of isocyanate type compounds include xylylene diisocyanate, hexamethylene diisocyanate, tolylene diisocyanate, and multimers, derivatives, and polymers thereof, and the like. These may be used singly or in combination of two or more.
- Examples of epoxy compounds include compounds having two or more epoxy groups in the molecule, and specific examples thereof include ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, glycerin diglycidyl ether, glycerin triglycidyl ether, 1,6-hexanediol diglycidyl ether, trimethylolpropane triglycidyl ether, diglycidylaniline, diamine glycidylamine, N,N,N′,N′-tetraglycidyl-m-xylylenediamine, 1,3-bis(N,N′-diamineglycidylaminomethyl), and the like. These may be used singly or in combination of two or more.
- In the present invention, the definition of the SP value is as described below.
- In the present invention, the SP value is a solubility parameter. The SP value can be determined by the following
Equation 1 with reference to the Fedors calculation method [“Polymer Engineering and Science,” Vol. 14, No. 2 (1974), pp. 148-154]. -
- In the
above Equation 1, δ is a solubility parameter (SP value), Δei is molar evaporation energy, and Δvi is molar volume. Further, the unit of the solubility parameter is (cal/mol)1/2. Table 1 shows the eigenvalues of Δei and Δvi given to the main atoms or atomic groups with respect to theabove Equation 1. -
TABLE 1 Atom or atomic group ei (cal/mol) vi (cm3/mol) C 350 −19.2 —CH2— 1180 16.1 —CH3 1125 33.5 CH2═ 1030 28.5 —CH═ 1030 13.5 -phenyl 7630 71.4 —O— 800 3.8 —CO— 4150 10.8 —COO— 4300 18.0 —OH 7120 10.0 —CONH2 10000 17.5 —CONH— 8000 9.5 —NH2 3000 19.2 —NH— 2000 4.5 —CN 6100 24.0 —COOH 6600 28.5 Si 810 0.0 F 1000 18.0 Cl 2760 24.0 - The SP value (solubility parameter) of the acrylic polymer is preferably 10.0 to 12.0, and more preferably 10.0 to 11.0.
- The SP value of the acrylic polymer can be controlled, for example, by changing the concentration of polar groups in the acrylic polymer. For example, when a relatively higher polar bond, such as an ether bond, is introduced into the side chain, the SP value tends to increase. On the other hand, when a relatively less polar bond, such as a long-chain alkylene bond, is introduced into the side chain, the SP value tends to decrease.
- In the agglutinant of the present invention, two or more acrylic polymers, such as two or more acrylic polymers having different weight average molecular weights, two or more acrylic polymers containing different monomer components, or two or more acrylic polymers with different copolymerization ratios, may be combined as the base material. In such case, within the range in which the effects of the present invention are exhibited, the SP value of only a single acrylic polymer may be within the range, or the SP values of all of the acrylic polymers may be out of the range, but the SP value of the entire acrylic polymer component may be within the range. Here, the SP value of the entire acrylic polymer component is calculated by dividing the SP value of each of two or more acrylic polymers proportionally by their respective mixing amounts.
- In order to reduce distortion and other influences on the mask substrate to which the pellicle is bonded, and to suppress residual stress due to pellicle bonding, the shape of the
agglutinant layer 14 is preferably a flat shape that is less likely to deform during bonding of the pellicle. - It was also found that more preferred results tended to be obtained when the agglutinant layer contained a polyvinyl ether compound. Specifically, when mixing was performed so that vinyl ether groups were uniformly dispersed in the whole agglutinant layer, the peeling properties of the agglutinant were further improved, and almost no residues were observed in the visual inspection. Even when the agglutinant layer in which vinyl ether groups were uniformly dispersed was bonded to a mask substrate and then irradiated with 193-nm ultraviolet rays, dust was hardly generated, and the probability of good peeling substantially without leaving peeling residues on the mask substrate was significantly increased.
- That is, in the best mode of the present invention, the pellicle uses, as a base material that constitutes the mask agglutinant layer, an acrylic polymer having an SP value of 10.0 or more and 12.0 or less, and contains a polyvinyl ether compound, whereby even when an exposure light beam is applied through the mask substrate, surface deterioration is reduced, and fine particulate residues are also reduced when the pellicle is peeled from the mask substrate. As a result, the regeneration cleaning of the mask substrate, from which the pellicle is peeled, proceeds smoothly, the cleaning conditions can be loosened, and there is an advantage in reducing damage to the mask surface during cleaning.
- Examples of the polyvinyl ether compound include homopolymers of vinyl ethers, such as methyl vinyl ether, ethyl vinyl ether, butyl vinyl ether, isobutyl vinyl ether, and (2-methoxyethyl) vinyl ether; copolymers of two or more vinyl ethers; copolymers of these vinyl ethers and other monomers; and the like. Among these, polyvinyl ether compounds containing methyl vinyl ether as a raw material monomer component are preferable in terms of the control of peeling residues.
- In the agglutinant that forms the
agglutinant layer 14, the mixing ratio of an acrylic polymer mentioned above, and the polyvinyl ether compound is, based on mass, 90:10 to 99:1, preferably 92:8 to 98:2, and particularly preferably 94:6 to 96:4, in terms of reducing peeling residues. - In addition, the agglutinant that forms the agglutinant layer of the pellicle may be mixed with other components, such as crosslinking agents, tackifiers, plasticizers, stabilizers, viscosity regulators, antistatic agents, lubricants, conductivity-imparting agents, flame retardancy-imparting agents, thermal conductivity-improving agents, heat resistance-improving agents, weather resistance-improving agents, thixotropy-imparting agents, antioxidants, antimicrobial agents, antifungal agents, and coloring agents, depending on the purpose within the range in which the characteristics of the present invention are not impaired.
- As the means for forming the
agglutinant layer 14, an uncured liquid or paste agglutinant is applied to the lower end face of thepellicle frame 11, followed by curing treatment, thereby forming an agglutinant layer. The agglutinant may be applied once, or may be repeatedly applied several times in order to obtain a predetermined thickness of the agglutinant layer. In this case, the agglutinant is preferably allowed to stand between each time of coating until the shape of the agglutinant after coating is stabilized. If it is difficult to apply an agglutinant due to its high viscosity, the agglutinant may be applied, if necessary, after dilution with an organic solvent, alcohol, water, or the like to reduce the viscosity of the agglutinant. The agglutinant can be applied, for example, by dipping, spraying, or brush coating, or by using a coating device with a dispenser or the like. Coating using a coating device with a dispenser is preferable, in terms of stability, workability, yield, and the like. - In the production of the
pellicle 10, the coating and formation of theagglutinant layer 14 are generally performed first, followed by stretching of thepellicle film 12; however, the order may be reversed. For stretching thepellicle film 12, for example, an adhesive material is applied to the upper end face of thepellicle frame 11, and thepellicle frame 11 is then heated to cure the adhesive material. Finally, the upper end face of thepellicle frame 11, on which theadhesive material layer 13 for bonding a pellicle film is formed, is bonded to a pellicle film taken in an aluminum frame larger than thepellicle frame 11, and extra portions of the pellicle film protruding outside thepellicle frame 11 are removed, thereby completing the pellicle. - Due to the use of the pellicle of the present invention with the configuration described above, the amount of agglutinant residues can be reduced when the pellicle is peeled from the exposure original plate after being used in lithography. Moreover, the present invention provides a method for reducing peeling residues of the agglutinant layer of the pellicle by using the pellicle of the present invention. Therefore, the pellicle of the present invention is useful as a pellicle bonded to a phase shift photo mask having the delicate phase shift film mentioned above, or a face comprising silicon oxide, such as quartz, as a main component.
- The pellicle of the present invention is also useful as a pellicle applied to exposure original plates whose agglutinant layer is irradiated with an exposure light beam during exposure, such as a negative type exposure original plate, an exposure original plate that has a non-shaded area or a semi-transparent shaded area in a portion thereof to which an agglutinant is bonded, and an exposure original plate that has a transparent area in a portion thereof to which an agglutinant is bonded. The agglutinant layer of the pellicle used in such an exposure original plate is exposed to an exposure light beam through the exposure original plate from the face of the exposure original plate opposite to the face provided with the pellicle.
- The pellicle of the present invention may be used not only as a protective member for suppressing the adhesion of foreign substances to the exposure original plate in the exposure device, but also as a protective member for protecting the exposure original plate during storage or transportation of the exposure original plate. An exposure original plate with a pellicle can be produced by mounting the pellicle described above on an exposure original plate, such as a photo mask.
- The method for producing a semiconductor device or a liquid crystal display board according to the present embodiment comprises a step of exposing a substrate (semiconductor wafer or liquid crystal original plate) using the exposure original plate with a pellicle described above. For example, in the lithography step, which is one of the steps for producing semiconductor devices or liquid crystal display boards, in order to form a photoresist pattern corresponding to an integrated circuit etc. on a substrate, the exposure original plate with a pellicle described above is set on a stepper to perform exposure. As a result, if foreign substances adhere to the pellicle in the lithography step, the foreign substances do not form images on the wafer coated with a photoresist; thus, the short circuit, disconnection, and the like of the integrated circuit etc. due to images of the foreign substances can be prevented. Therefore, the use of the exposure original plate with a pellicle can improve the yield in the lithography step.
- In general, when a desired number of times of lithography steps are performed, when foreign substances and haze are generated, or when the pellicle film is damaged, the pellicle is peeled from the exposure original plate, and the exposure original plate is subjected to regeneration cleaning in some cases. Due to the use of the pellicle of the present invention, peeling residues during repellicle can be reduced even in the case of exposure original plates whose agglutinant layer is irradiated with an exposure light beam during exposure, such as an exposure original plate having a face comprising silicon oxide as a main component in which peeling residues of the agglutinant layer are likely to be generated, a negative type exposure original plate whose agglutinant layer is irradiated with an exposure light beam more than before, an exposure original plate that has a non-shaded area or a semi-transparent shaded area in a portion thereof to which an agglutinant is bonded, whose agglutinant layer is irradiated with an exposure light beam more than before, and an exposure original plate that has a transparent area in a portion thereof to which an agglutinant is bonded, whose agglutinant layer is irradiated with an exposure light beam more than before.
- Moreover, since the use of the pellicle of the present invention can reduce peeling residues of the agglutinant layer, cleaning with functional water can be easily applied, and cleaning properties for delicate exposure original plates, such as phase shift photo masks, can be improved. In addition, the use of the pellicle of the present invention can contribute to the reduction of environmental burden caused by cleaning with functional water.
- The present invention will be described in more detail below with reference to Examples. The “mask” in the Examples and Comparative Examples is described as an example of the “exposure original plate.” Needless to say, it can also be applied to reticles.
- After a pellicle frame (external size: 149 mm×115 mm×3.5 mm, thickness: 2 mm, flatness of an end face coated with a mask bonding agglutinant: 15 um) made of an aluminum alloy was subjected to precision cleaning, an acrylic agglutinant manufactured by Soken Chemical Co., Ltd. (product name: SK-Dyne SN-70A, containing, as a base material, an acrylic polymer in which 95 mass % of monomer components was an ethylene oxide group-containing (meth)acrylate; SP value of the base material: 10.2) was applied to the end face with a flatness of 15 um, and allowed to stand for 60 minutes at room temperature. Thereafter, a separator was placed on an aluminum plate with a flatness of 5 um, and the pellicle frame coated with the agglutinant was placed so that the agglutinant faced down. Thus, the agglutinant was brought into contact with the flat separator and flattened.
- Next, the pellicle on the aluminum plate was placed in an oven at 60° C. for 60 minutes to cure the agglutinant.
- After the pellicle together with the aluminum plate was taken out from the oven, the separator was peeled.
- Thereafter, an adhesive material manufactured by AGC Inc. (trade name: Cytop CTX-A) was applied to the end face opposite to the end face coated with the agglutinant. Then, the pellicle frame was heated at 130° C. to cure the adhesive material.
- Finally, the adhesive material-coated end face of the pellicle frame was bonded to a pellicle film taken in an aluminum flame larger than the pellicle frame, and portions outside the pellicle frame were removed, thereby completing the pellicle.
- Next, a 6025 mask substrate (6 inch) and the previously prepared pellicle were set in a bonding device, and pressurized at a bonding load of 50 N for a load time of 30 seconds to bond the pellicle to the mask substrate.
- After the mask substrate to which the pellicle was bonded was left for 24 hours at room temperature, the back surface of the mask was irradiated with ultraviolet rays at 10 mJ/cm2 using a 193-nm ultraviolet lamp so that the light beam was applied to the pellicle agglutinant.
- After ultraviolet irradiation, the resultant was left for 1 hour at room temperature, and then the pellicle was slowly peeled upward from the mask substrate at a speed of 0.1 mm/sec.
- When the mask substrate after peeling was visually observed, a pale opaque band, which was considered to be agglutinant solute residues, was slightly found in the contour portion to which the pellicle was bonded, and the surface of the mask substrate was obviously cleaner than the Comparative Examples, described later. The residues could be removed by cleaning for 5 minutes in a cleaning tank using functional water (hydrogen and ammonia were added to ultrapure water) in combination with ultrasonic waves (functional water overflowed).
- A pellicle was completed in the same manner using the same materials as in Example 1, except that the agglutinant used herein was an acrylic agglutinant manufactured by Soken Chemical Co., Ltd. (product name: SN-25B, containing, as a base material, an acrylic polymer in which 40 mass % of monomer components was an ethylene oxide group-containing (meth)acrylate; SP value of the base material: 10.5). Further, the pellicle was bonded to and peeled from a mask substrate under the same conditions as in Example 1.
- When the mask substrate after peeling was visually observed, a pale opaque band, which was considered to be agglutinant solute residues, was slightly found in the contour portion to which the pellicle was bonded, and the surface of the mask substrate was obviously cleaner than the Comparative Examples, described later. The residues could be removed by cleaning for 5 minutes twice in a cleaning tank using functional water (hydrogen and ammonia were added to ultrapure water) in combination with ultrasonic waves (functional water overflowed), as in Example 1.
- A pellicle was completed in the same manner using the same materials as in Example 1, except that the agglutinant used herein contained 3 mass parts of a polyvinyl ether compound based on 100 mass parts of SK-Dyne SN-70A. Further, the pellicle was bonded to and peeled from a mask substrate under the same conditions as in Example 1.
- When the mask substrate after peeling was visually observed, a pale shiny transparent band, which was considered to be agglutinant solute residues, was slightly found in the contour portion to which the pellicle was bonded, and the mask substrate was so clean that almost no agglutinant solute residue was confirmed. As for the subsequent cleaning, the residues could be removed by cleaning for 3 minutes using the same equipment as in Example 1.
- A pellicle was completed in the same manner using the same materials as in Example 1, except that the agglutinant used herein was an acrylic agglutinant manufactured by Soken Chemical Co., Ltd. (product name: SK-Dyne SK-1425S, containing, as a base material, an acrylic polymer not containing a (meth)acrylic acid ester having an ether bond as a monomer component; SP value of the base material: 9.8). Further, the pellicle was bonded to and peeled from a mask substrate under the same conditions as in Example 1.
- When the mask substrate after peeling was visually observed, pale agglutinant solute residues were found in the portion to which the pellicle was bonded. The peeling residues could not be completely removed by cleaning for 5 minutes twice using the same equipment as in Example 1. Accordingly, light rubbing using a foamed polyvinyl alcohol was necessary before cleaning.
- A pellicle was completed in the same manner using the same materials as in Example 1, except that the agglutinant used herein was an acrylic agglutinant manufactured by Soken Chemical Co., Ltd. (product name: SK-Dyne SK-1495S, containing, as a base material, an acrylic polymer not containing a (meth)acrylic acid ester having an ether bond as a monomer component; SP value of the base material: 9.2). Further, the pellicle was bonded to and peeled from a mask substrate under the same conditions as in Example 1.
- When the mask substrate after peeling was visually observed, pale agglutinant solute residues were found in the portion to which the pellicle was bonded. The peeling residues could not be removed only by ultrasonic cleaning with functional water, as in Comparative Example 1, but could be removed by the combined use of rubbing cleaning with a foamed polyvinyl alcohol before ultrasonic cleaning.
- A 5-L flask equipped with a stirrer, a reflux condenser, a thermometer, and a gas inlet was charged with 320 g of butyl acrylate, 550 g of 2-methoxyethyl acrylate, 80 g of acrylic acid, 50 g of 2-hydroxyethyl acrylate, 1500 g of ethyl acetate, and 2 g of azobisisobutyronitrile as a polymerization initiator. Solution polymerization was carried out at 68° C. for 8 hours in a nitrogen gas stream. After the completion of the reaction, 830 g of ethyl acetate was added thereto, thereby obtaining a solution of an acrylic polymer with a solid content of 30% (SP value: 10.6). A polyisocyanate solution was added to the obtained acrylic polymer solution, and the mixture was stirred and mixed to obtain an agglutinant.
- A 5-L flask equipped with a stirrer, a reflux condenser, a thermometer, and a gas inlet was charged with 400 g of 2-ethylhexyl acrylate, 500 g of 2-ethoxyethyl acrylate, 100 g of acrylic acid, 1200 g of ethyl acetate, and 2 g of azobisisobutyronitrile as a polymerization initiator. Solution polymerization was carried out at 68° C. for 8 hours in a nitrogen gas stream. After the completion of the reaction, 1130 g of ethyl acetate was added thereto, thereby obtaining a solution of an acrylic polymer with a solid content of 30% (SP value: 10.1). A polyisocyanate solution was added to the obtained acrylic polymer solution, and the mixture was stirred and mixed to obtain an agglutinant.
- A 5-L flask equipped with a stirrer, a reflux condenser, a thermometer, and a gas inlet was charged with 350 g of 2-ethylhexyl acrylate, 550 g of 2-methoxyethyl acrylate, 50 g of methacrylic acid, 50 g of 2-hydroxyethyl methacrylate, 1400 g of ethyl acetate, and 2 g of azobisisobutyronitrile as a polymerization initiator. Solution polymerization was carried out at 68° C. for 8 hours in a nitrogen gas stream. After the completion of the reaction, 930 g of ethyl acetate was added thereto, thereby obtaining a solution of an acrylic polymer with a solid content of 30% (SP value: 10.2). A polyisocyanate solution was added to the obtained acrylic polymer solution, and the mixture was stirred and mixed to obtain an agglutinant.
- A 5-L flask equipped with a stirrer, a reflux condenser, a thermometer, and a gas inlet was charged with 300 g of butyl acrylate, 550 g of 2-methoxyethyl acrylate, 100 g of 2-hydroxybutyl acrylate, 50 g of itaconic acid, 1500 g of ethyl acetate, and 2 g of azobisisobutyronitrile as a polymerization initiator. Solution polymerization was carried out at 68° C. for 8 hours in a nitrogen gas stream. After the completion of the reaction, 830 g of ethyl acetate was added thereto, thereby obtaining a solution of an acrylic polymer with a solid content of 30% (SP value: about 10.7). A polyisocyanate solution was added to the obtained acrylic polymer solution, and the mixture was stirred and mixed to obtain an agglutinant.
- A 5-L flask equipped with a stirrer, a reflux condenser, a thermometer, and a gas inlet was charged with 300 g of butyl acrylate, 600 g of methoxypolyethylene glycol acrylate, 100 g of acrylic acid, 1400 g of ethyl acetate, and 2 g of azobisisobutyronitrile as a polymerization initiator. Solution polymerization was carried out at 68° C. for 8 hours in a nitrogen gas stream. After the completion of the reaction, 930 g of ethyl acetate was added thereto, thereby obtaining a solution of an acrylic polymer with a solid content of 30% (SP value: about 10). A polyisocyanate solution was added to the obtained acrylic polymer solution, and the mixture was stirred and mixed to obtain an agglutinant.
- Pellicles were produced in the same manner as in Example 1, except that the agglutinant used herein was each of the agglutinants obtained in Synthesis Examples 1 to 5, and a peeling test was performed. As a result, the pellicles using any of the agglutinants resulted in reduced peeling residues and had improved cleaning removing properties, compared with the Comparative Examples.
-
- 1: exposure original plate
- 10: pellicle
- 11: pellicle frame
- 12: pellicle film
- 13: adhesive material layer for bonding pellicle film
- 14: agglutinant layer
- 15: air pressure adjustment hole (vent)
- 16: dust removal filter
Claims (33)
1. An agglutinant for pellicles for bonding a pellicle to an exposure original plate, the agglutinant comprising an acrylic polymer having an SP value of 10.0 or more and 12.0 or less as a base material.
2. An agglutinant for pellicles for bonding a pellicle to an exposure original plate, the agglutinant comprising an acrylic polymer as a base material, the acrylic polymer comprising a (meth)acrylic acid ester having an ether bond as a monomer component.
3. An agglutinant for pellicles as claimed in claim 2 , wherein the (meth)acrylic acid ester having an ether bond is a (meth)acrylic acid ester having an alkylene oxide group.
4. An agglutinant for pellicles as claimed in claim 3 , wherein the (meth)acrylic acid ester having an ether bond is contained in an amount of 30 mass % or more based on the whole monomer components.
5. An agglutinant for pellicles as claimed in claim 3 , wherein the alkylene oxide group is an ethylene oxide group.
6. An agglutinant for pellicles as claimed in claim 2 , further comprising an unsaturated monomer having a carboxyl group or a hydroxyl group as a monomer component.
7. An agglutinant for pellicles as claimed in claim 2 , further comprising a (meth)acrylic acid alkyl ester as a monomer component.
8. An agglutinant for pellicles for bonding a pellicle to an exposure original plate, the agglutinant comprising an acrylic polymer as a base material, the acrylic polymer having a side chain containing an ether bond.
9. An agglutinant for pellicles as claimed in claim 8 , wherein the side chain containing an ether bond has an alkylene oxide group.
10. An agglutinant for pellicles as claimed in claim 9 , wherein the alkylene oxide group is an ethylene oxide group.
11. An agglutinant for pellicles for bonding a pellicle to an exposure original plate, the agglutinant comprising an acrylic polymer as a base material, the acrylic polymer having a side chain that has higher degradability by irradiation with an exposure light beam than a main chain.
12. An agglutinant for pellicles for bonding a pellicle to an exposure original plate, the agglutinant comprising an acrylic polymer as a base material, the acrylic polymer having a side chain that is selectively degraded by irradiation with an exposure light beam.
13. A pellicle frame with an agglutinant layer, comprising a pellicle frame and an agglutinant layer provided on one end face of the pellicle frame and obtained from an agglutinant for pellicles as claimed in claim 1 .
14. A pellicle comprising a pellicle film, a pellicle frame provided with the pellicle film on one end face thereof, and an agglutinant layer provided on the other end face of the pellicle frame and obtained from an agglutinant for pellicles as claimed in claim 1 .
15. A pellicle as claimed in claim 14 , wherein the agglutinant layer is irradiated with an exposure light beam.
16. A pellicle as claimed in claim 14 , wherein the pellicle is bonded to a phase shift photo mask.
17. A pellicle as claimed in claim 14 , wherein the pellicle is bonded to a negative type exposure original plate.
18. A pellicle as claimed in claim 14 , wherein the pellicle is bonded to an exposure original plate that has a non-shaded area or a semi-transparent shaded area in a portion thereof to which an agglutinant layer is bonded.
19. A pellicle as claimed in claim 14 , wherein the pellicle is bonded to an exposure original plate that has a transparent area in a portion thereof to which an agglutinant layer is bonded.
20. A pellicle as claimed in claim 14 , wherein the pellicle is bonded to a face comprising silicon oxide as a main component.
21. A pellicle as claimed in claim 20 , wherein the face comprising silicon oxide as a main component is a quartz face.
22. A pellicle as claimed in claim 14 , wherein the pellicle is compatible with regeneration cleaning with functional water.
23. An exposure original plate with a pellicle, comprising an exposure original plate and a pellicle as claimed in claim 14 mounted on the exposure original plate.
24. An exposure original plate with a pellicle as claimed in claim 23 , wherein the exposure original plate is a phase shift photo mask.
25. An exposure original plate with a pellicle as claimed in claim 23 , wherein the exposure original plate is of negative type.
26. An exposure original plate with a pellicle as claimed in claim 23 , wherein a portion of the exposure original plate to which the agglutinant layer is bonded has a non-shaded area or a semi-transparent shaded area.
27. An exposure original plate with a pellicle as claimed in claim 23 , wherein a portion of the exposure original plate to which the agglutinant layer is bonded has a transparent area.
28. An exposure original plate with a pellicle as claimed in claim 23 , wherein the exposure original plate comprises silicon oxide as a main component.
29. An exposure original plate with a pellicle as claimed in claim 23 , wherein the exposure original plate is a quartz substrate.
30. A method for producing a semiconductor device, comprising a step of performing exposure using an exposure original plate with a pellicle as claimed in claim 23 .
31. A method for producing a liquid crystal display board, comprising a step of performing exposure using an exposure original plate with a pellicle as claimed in claim 23 .
32. A method for regenerating an exposure original plate, comprising peeling a pellicle from an exposure original plate with a pellicle as claimed in claim 23 , and cleaning residues of an agglutinant remaining on the exposure original plate with functional water to regenerate the exposure original plate.
33. A peeling residue reduction method comprising, when peeling a pellicle from an exposure original plate to which the pellicle is bonded, reducing peeling residues of an agglutinant layer of the pellicle remaining on the exposure original plate, wherein the method uses a pellicle as claimed in claim 14 as the pellicle.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019077837 | 2019-04-16 | ||
JP2019-077837 | 2019-04-16 | ||
JP2019082301 | 2019-04-23 | ||
JP2019-082301 | 2019-04-23 | ||
JP2019082302 | 2019-04-23 | ||
JP2019-082302 | 2019-04-23 | ||
PCT/JP2020/016626 WO2020213661A1 (en) | 2019-04-16 | 2020-04-15 | Adhesive agent for pellicles, pellicle, pellicle-attached exposure original plate, method for manufacturing semiconductor device, method for manufacturing liquid crystal display panel, method for regenerating exposure original plate, and method for reducing peeling residue |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220214612A1 true US20220214612A1 (en) | 2022-07-07 |
Family
ID=72837183
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/603,930 Pending US20220214611A1 (en) | 2019-04-16 | 2020-04-15 | Pellicle, Exposure Original Plate with Pellicle, Method for Producing Semiconductor Device, Method for Producing Liquid Crystal Display Board, Method for Regenerating Exposure Original Plate, and Peeling Residue Reduction Method |
US17/603,933 Pending US20220214613A1 (en) | 2019-04-16 | 2020-04-15 | Agglutinant for Pellicle, Pellicle, Exposure Original Plate with Pellicle, Method for Producing Semiconductor Device, Method for Producing Liquid Crystal Display Board, Method for Regenerating Exposure Original Plate, and Peeling Residue Reduction Method |
US17/603,932 Pending US20220214612A1 (en) | 2019-04-16 | 2020-04-15 | Agglutinant for Pellicle, Pellicle, Exposure Original Plate with Pellicle, Method for Producing Semiconductor Device, Method for Producing Liquid Crystal Display Board, Method for Regenerating Exposure Original Plate, and Peeling Residue Reduction Method |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/603,930 Pending US20220214611A1 (en) | 2019-04-16 | 2020-04-15 | Pellicle, Exposure Original Plate with Pellicle, Method for Producing Semiconductor Device, Method for Producing Liquid Crystal Display Board, Method for Regenerating Exposure Original Plate, and Peeling Residue Reduction Method |
US17/603,933 Pending US20220214613A1 (en) | 2019-04-16 | 2020-04-15 | Agglutinant for Pellicle, Pellicle, Exposure Original Plate with Pellicle, Method for Producing Semiconductor Device, Method for Producing Liquid Crystal Display Board, Method for Regenerating Exposure Original Plate, and Peeling Residue Reduction Method |
Country Status (7)
Country | Link |
---|---|
US (3) | US20220214611A1 (en) |
EP (3) | EP3958059A4 (en) |
JP (8) | JP6793895B1 (en) |
KR (3) | KR20220005014A (en) |
CN (3) | CN113966487A (en) |
TW (8) | TW202109178A (en) |
WO (3) | WO2020213661A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220113623A1 (en) * | 2020-10-14 | 2022-04-14 | Shin-Etsu Chemical Co., Ltd. | Agglutinant for Pellicles, Pellicle Frame with Agglutinant Layer, Pellicle, Exposure Original Plate with Pellicle, Exposure Method, Method for Producing Semiconductor, and Method for Producing Liquid Crystal Display Board |
US20220214611A1 (en) * | 2019-04-16 | 2022-07-07 | Shin-Etsu Chemical Co., Ltd. | Pellicle, Exposure Original Plate with Pellicle, Method for Producing Semiconductor Device, Method for Producing Liquid Crystal Display Board, Method for Regenerating Exposure Original Plate, and Peeling Residue Reduction Method |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7390226B2 (en) * | 2020-03-18 | 2023-12-01 | 綜研化学株式会社 | Adhesive composition, adhesive layer and adhesive sheet |
JPWO2023149347A1 (en) * | 2022-02-04 | 2023-08-10 | ||
WO2023149343A1 (en) * | 2022-02-04 | 2023-08-10 | 三井化学株式会社 | Pellicle, exposure original plate, exposure device, method for manufacturing pellicle, and method for testing pressure-sensitive adhesive layer for mask |
Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03109477A (en) * | 1989-09-22 | 1991-05-09 | Nitto Denko Corp | Moisture curing type tacky agent composition |
JPH05107745A (en) * | 1991-10-18 | 1993-04-30 | Seiko Epson Corp | Manufacture of photomask and semiconductor device |
JPH11140410A (en) * | 1997-11-13 | 1999-05-25 | Mitsubishi Rayon Co Ltd | Ultraviolet-curable tack agent composition |
JP2001123136A (en) * | 1999-10-28 | 2001-05-08 | Soken Chem & Eng Co Ltd | Moisture-resistant adhesive sheet and its use |
JP2003036293A (en) * | 2001-07-26 | 2003-02-07 | Matsushita Electric Works Ltd | Method for supporting business, manufacturing and purchase, system using the method, and recording medium |
US20030036293A1 (en) * | 2001-08-17 | 2003-02-20 | Hitachi, Ltd. | Method for manufacturing a semiconductor device |
JP2007156397A (en) * | 2005-05-09 | 2007-06-21 | Mitsui Chemicals Inc | Hardly contaminating pellicle and method for producing the same |
JP2010002895A (en) * | 2008-05-19 | 2010-01-07 | Asahi Kasei E-Materials Corp | Adhesive material composition for pellicle |
US20100279212A1 (en) * | 2009-04-30 | 2010-11-04 | Shin-Etsu Chemical Co., Ltd. | Photomask |
JP2013134481A (en) * | 2011-12-27 | 2013-07-08 | Asahi Kasei E-Materials Corp | Pellicle |
JP2013224431A (en) * | 2013-05-20 | 2013-10-31 | Toyo Ink Sc Holdings Co Ltd | Optical pressure-sensitive adhesive agent, and optical pressure-sensitive adhesive sheet |
US20140178620A1 (en) * | 2012-02-28 | 2014-06-26 | Nitto Denko Corporation | Film for pressure-sensitive adhesive tape and pressure-sensitive adhesive tape |
US20150357223A1 (en) * | 2014-05-13 | 2015-12-10 | Nitto Denko Corporation | Dicing-tape integrated film for backside of semiconductor and method of manufacturing semiconductor device |
JP2016173414A (en) * | 2015-03-16 | 2016-09-29 | 旭化成株式会社 | Pellicle |
US20170088755A1 (en) * | 2015-09-30 | 2017-03-30 | Samsung Electronics Co., Ltd. | Pellicle including a water-soluble adhesive and photomask assembly including the pellicle |
JP2017179111A (en) * | 2016-03-30 | 2017-10-05 | 日本カーバイド工業株式会社 | Adhesive composition for decorative film, decorative film and decorative molded article |
JP2018024782A (en) * | 2016-08-10 | 2018-02-15 | 日本カーバイド工業株式会社 | Adhesive composition and adhesive sheet |
US20190322991A1 (en) * | 2016-06-30 | 2019-10-24 | Cj Cheiljedang Corporation | Method for enzymatically preparing highly concentrated myo-inositol |
US20220113623A1 (en) * | 2020-10-14 | 2022-04-14 | Shin-Etsu Chemical Co., Ltd. | Agglutinant for Pellicles, Pellicle Frame with Agglutinant Layer, Pellicle, Exposure Original Plate with Pellicle, Exposure Method, Method for Producing Semiconductor, and Method for Producing Liquid Crystal Display Board |
US20220214613A1 (en) * | 2019-04-16 | 2022-07-07 | Shin-Etsu Chemical Co., Ltd. | Agglutinant for Pellicle, Pellicle, Exposure Original Plate with Pellicle, Method for Producing Semiconductor Device, Method for Producing Liquid Crystal Display Board, Method for Regenerating Exposure Original Plate, and Peeling Residue Reduction Method |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3287205A (en) * | 1962-09-24 | 1966-11-22 | Union Carbide Corp | Low temperature bonding thermoplastic polyhydroxyether adhesive compositions |
US3308002A (en) * | 1963-11-27 | 1967-03-07 | Dymo Industries Inc | Method and apparatus for application of pressure sensitive adhesive material |
US4033918A (en) * | 1972-03-24 | 1977-07-05 | Beiersdorf Aktiengesellschaft | Water removable pressure sensitive adhesive |
JPS5513616B2 (en) | 1975-02-06 | 1980-04-10 | ||
JPS53147827A (en) | 1976-06-14 | 1978-12-22 | Kaji Tetsukoushiyo Kk | Double twisting direct twisting frame |
JP3037745B2 (en) * | 1990-11-29 | 2000-05-08 | 三井化学株式会社 | Pellicle structure |
JPH05209160A (en) * | 1991-10-11 | 1993-08-20 | Sekisui Chem Co Ltd | Water-soluble tack agent composition, solder masking agent, adhesive tape and production of adhesive tape |
DE4216359A1 (en) * | 1992-05-18 | 1993-12-02 | Hoechst Ag | Method for producing a multicolor image and photosensitive material for carrying out this process |
JPH06148871A (en) * | 1992-10-30 | 1994-05-27 | Tosoh Corp | Pellicle and production of pellicle |
JP2944862B2 (en) * | 1993-08-30 | 1999-09-06 | 株式会社クボタ | Wheel-wheel adjusting device and wheel-wheel adjusting method for four-wheel drive tractor |
JP3071348B2 (en) * | 1993-10-21 | 2000-07-31 | 信越化学工業株式会社 | Pellicle and its peeling method |
JP3408000B2 (en) * | 1994-11-28 | 2003-05-19 | 菱電セミコンダクタシステムエンジニアリング株式会社 | Pellicle peeling method |
JP2001022052A (en) * | 1999-07-05 | 2001-01-26 | Shin Etsu Chem Co Ltd | Pellicle for lithography |
JP2001083691A (en) * | 1999-09-13 | 2001-03-30 | Asahi Kasei Electronics Co Ltd | Pellicle free from occurrence of dust |
EP1238310A1 (en) * | 1999-11-17 | 2002-09-11 | E.I. Du Pont De Nemours And Company | Ultraviolet and vacuum ultraviolet transparent polymer compositions and their uses |
JP4458315B2 (en) * | 2000-06-02 | 2010-04-28 | 旭化成イーマテリアルズ株式会社 | Pellicle |
KR100405311B1 (en) * | 2000-12-29 | 2003-11-12 | 주식회사 엘지화학 | Acrylic pressure sensitive adhesive for the polarizing firm |
JP2003096215A (en) * | 2001-09-21 | 2003-04-03 | Teijin Dupont Films Japan Ltd | Near infrared shielding film and laminate using the same |
JP2003082302A (en) * | 2001-09-13 | 2003-03-19 | Tomoegawa Paper Co Ltd | Film with pigmented adhesive for electronic display |
JP2005171211A (en) * | 2003-12-08 | 2005-06-30 | Hitachi Kasei Polymer Co Ltd | Processed tacky adhesive product of photosensitive film |
JP2006146085A (en) | 2004-11-24 | 2006-06-08 | Shin Etsu Chem Co Ltd | Large pellicle |
JP4984657B2 (en) * | 2005-07-06 | 2012-07-25 | 大日本印刷株式会社 | Hologram observation sheet |
JP4936515B2 (en) * | 2006-05-18 | 2012-05-23 | Hoya株式会社 | Photomask manufacturing method and halftone phase shift mask manufacturing method |
JP4764275B2 (en) | 2006-07-13 | 2011-08-31 | 三菱電機株式会社 | Adjustment request support device, delivery date response / shipment adjustment system and delivery date response / shipment adjustment method |
JP5871297B2 (en) * | 2007-11-02 | 2016-03-01 | 日東電工株式会社 | Adhesive optical film, method for producing the same, and image display device |
KR20100055161A (en) * | 2008-11-17 | 2010-05-26 | 주식회사 엘지화학 | Pressure-sensitive adhesive compositions and pressure-sensitive adhesive films comprising the same |
JP2010189545A (en) * | 2009-02-18 | 2010-09-02 | Nitto Denko Corp | Double-sided self-adhesive sheet and self-adhesive optical member |
JP5364491B2 (en) * | 2009-07-24 | 2013-12-11 | リンテック株式会社 | Adhesive sheet |
JP6105188B2 (en) * | 2009-11-18 | 2017-03-29 | 旭化成株式会社 | Pellicle |
CN102971673B (en) * | 2010-07-09 | 2015-10-07 | 三井化学株式会社 | Protective film assembly and the mask adhesive for protective film assembly |
JP5372084B2 (en) * | 2010-09-17 | 2013-12-18 | オビカワ株式会社 | Protective body and method of manufacturing the protective body |
WO2012157759A1 (en) | 2011-05-18 | 2012-11-22 | 旭化成イーマテリアルズ株式会社 | Pellicle, pressure-sensitive adhesive for pellicle, photomask with pellicle, and method for manufacturing semiconductor device |
WO2012161660A1 (en) * | 2011-05-23 | 2012-11-29 | National University Of Singapore | Method of transferring thin films |
JP5981191B2 (en) * | 2012-03-28 | 2016-08-31 | 旭化成株式会社 | Pellicle frame |
US10711162B2 (en) * | 2013-10-11 | 2020-07-14 | Daicel Corporation | Adhesive agent |
TWI633147B (en) * | 2013-11-25 | 2018-08-21 | Kuraray Co., Ltd. | Acrylic resin film and manufacturing method thereof |
JP6569189B2 (en) * | 2014-04-01 | 2019-09-04 | 大日本印刷株式会社 | Imprint mold substrate and method for producing the same, imprint method, imprint mold and method for regenerating the same |
JP6316686B2 (en) | 2014-07-04 | 2018-04-25 | 旭化成株式会社 | Pellicle, photomask with pellicle, and method for manufacturing semiconductor device |
JP2016031412A (en) * | 2014-07-28 | 2016-03-07 | 凸版印刷株式会社 | Apparatus and method for washing off adhesive of pellicle of photomask |
KR101821239B1 (en) * | 2015-09-04 | 2018-01-24 | 주식회사 이오테크닉스 | Method and apparatus for removing adhesive |
KR101700092B1 (en) * | 2015-09-30 | 2017-01-26 | 주식회사 에스폴리텍 | Manufacturing method of case for photomask transporting tray |
JP2017090719A (en) * | 2015-11-11 | 2017-05-25 | 旭化成株式会社 | Pellicle |
WO2018008594A1 (en) * | 2016-07-05 | 2018-01-11 | 三井化学株式会社 | Pellicle film, pellicle frame, pellicle, method for producing same, original plate for light exposure, light exposure apparatus and method for manufacturing semiconductor device |
US10353283B2 (en) * | 2016-07-11 | 2019-07-16 | Shin-Etsu Chemical Co., Ltd. | Adhesive for pellicle, pellicle, and method of selecting adhesive for pellicle |
JP2018013583A (en) * | 2016-07-20 | 2018-01-25 | 住友化学株式会社 | Optical film having separator film laminate adhesive layer |
JP6607574B2 (en) * | 2016-08-24 | 2019-11-20 | 信越化学工業株式会社 | Pellicle frame and pellicle |
JP6706575B2 (en) * | 2016-12-22 | 2020-06-10 | 信越化学工業株式会社 | Pellicle frame and pellicle using the same |
JP6993687B2 (en) * | 2017-02-23 | 2022-01-13 | 国立大学法人東京農工大学 | Turbine blade cooling method |
US11958967B2 (en) * | 2017-06-22 | 2024-04-16 | Teraoka Seisakusho Co., Ltd. | Acrylic resin composition, adhesive agent composition, base for adhesive sheet, and adhesive sheet |
-
2020
- 2020-04-15 TW TW109112658A patent/TW202109178A/en unknown
- 2020-04-15 US US17/603,930 patent/US20220214611A1/en active Pending
- 2020-04-15 TW TW109143145A patent/TWI724983B/en active
- 2020-04-15 KR KR1020217037397A patent/KR20220005014A/en unknown
- 2020-04-15 KR KR1020217037393A patent/KR20210153109A/en unknown
- 2020-04-15 KR KR1020217037394A patent/KR20220002381A/en unknown
- 2020-04-15 WO PCT/JP2020/016626 patent/WO2020213661A1/en unknown
- 2020-04-15 TW TW109143195A patent/TWI726832B/en active
- 2020-04-15 TW TW110114030A patent/TWI740799B/en active
- 2020-04-15 JP JP2020542476A patent/JP6793895B1/en active Active
- 2020-04-15 TW TW109112635A patent/TW202105051A/en unknown
- 2020-04-15 TW TW109143178A patent/TWI739691B/en active
- 2020-04-15 JP JP2020539308A patent/JP6799723B1/en active Active
- 2020-04-15 WO PCT/JP2020/016628 patent/WO2020213662A1/en unknown
- 2020-04-15 TW TW111124896A patent/TW202242062A/en unknown
- 2020-04-15 TW TW109112650A patent/TW202100702A/en unknown
- 2020-04-15 WO PCT/JP2020/016624 patent/WO2020213659A1/en unknown
- 2020-04-15 CN CN202080041531.9A patent/CN113966487A/en active Pending
- 2020-04-15 US US17/603,933 patent/US20220214613A1/en active Pending
- 2020-04-15 EP EP20791361.7A patent/EP3958059A4/en active Pending
- 2020-04-15 JP JP2020542454A patent/JP6793894B1/en active Active
- 2020-04-15 CN CN202080041500.3A patent/CN114144728A/en active Pending
- 2020-04-15 EP EP20791599.2A patent/EP3958060A4/en active Pending
- 2020-04-15 EP EP20791600.8A patent/EP3958061A4/en active Pending
- 2020-04-15 CN CN202080041511.1A patent/CN113924526A/en active Pending
- 2020-04-15 US US17/603,932 patent/US20220214612A1/en active Pending
- 2020-07-16 JP JP2020122013A patent/JP2021009391A/en active Pending
- 2020-08-05 JP JP2020133246A patent/JP2020200468A/en active Pending
- 2020-08-05 JP JP2020133230A patent/JP2020194182A/en active Pending
- 2020-10-20 JP JP2020176099A patent/JP6859479B2/en active Active
- 2020-11-26 JP JP2020195963A patent/JP7059339B2/en active Active
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03109477A (en) * | 1989-09-22 | 1991-05-09 | Nitto Denko Corp | Moisture curing type tacky agent composition |
JPH05107745A (en) * | 1991-10-18 | 1993-04-30 | Seiko Epson Corp | Manufacture of photomask and semiconductor device |
JPH11140410A (en) * | 1997-11-13 | 1999-05-25 | Mitsubishi Rayon Co Ltd | Ultraviolet-curable tack agent composition |
JP2001123136A (en) * | 1999-10-28 | 2001-05-08 | Soken Chem & Eng Co Ltd | Moisture-resistant adhesive sheet and its use |
JP2003036293A (en) * | 2001-07-26 | 2003-02-07 | Matsushita Electric Works Ltd | Method for supporting business, manufacturing and purchase, system using the method, and recording medium |
US20030036293A1 (en) * | 2001-08-17 | 2003-02-20 | Hitachi, Ltd. | Method for manufacturing a semiconductor device |
JP2007156397A (en) * | 2005-05-09 | 2007-06-21 | Mitsui Chemicals Inc | Hardly contaminating pellicle and method for producing the same |
JP2010002895A (en) * | 2008-05-19 | 2010-01-07 | Asahi Kasei E-Materials Corp | Adhesive material composition for pellicle |
US20100279212A1 (en) * | 2009-04-30 | 2010-11-04 | Shin-Etsu Chemical Co., Ltd. | Photomask |
JP2013134481A (en) * | 2011-12-27 | 2013-07-08 | Asahi Kasei E-Materials Corp | Pellicle |
US20140178620A1 (en) * | 2012-02-28 | 2014-06-26 | Nitto Denko Corporation | Film for pressure-sensitive adhesive tape and pressure-sensitive adhesive tape |
JP2013224431A (en) * | 2013-05-20 | 2013-10-31 | Toyo Ink Sc Holdings Co Ltd | Optical pressure-sensitive adhesive agent, and optical pressure-sensitive adhesive sheet |
US20150357223A1 (en) * | 2014-05-13 | 2015-12-10 | Nitto Denko Corporation | Dicing-tape integrated film for backside of semiconductor and method of manufacturing semiconductor device |
JP2016173414A (en) * | 2015-03-16 | 2016-09-29 | 旭化成株式会社 | Pellicle |
US20170088755A1 (en) * | 2015-09-30 | 2017-03-30 | Samsung Electronics Co., Ltd. | Pellicle including a water-soluble adhesive and photomask assembly including the pellicle |
JP2017179111A (en) * | 2016-03-30 | 2017-10-05 | 日本カーバイド工業株式会社 | Adhesive composition for decorative film, decorative film and decorative molded article |
US20190322991A1 (en) * | 2016-06-30 | 2019-10-24 | Cj Cheiljedang Corporation | Method for enzymatically preparing highly concentrated myo-inositol |
JP2018024782A (en) * | 2016-08-10 | 2018-02-15 | 日本カーバイド工業株式会社 | Adhesive composition and adhesive sheet |
US20220214613A1 (en) * | 2019-04-16 | 2022-07-07 | Shin-Etsu Chemical Co., Ltd. | Agglutinant for Pellicle, Pellicle, Exposure Original Plate with Pellicle, Method for Producing Semiconductor Device, Method for Producing Liquid Crystal Display Board, Method for Regenerating Exposure Original Plate, and Peeling Residue Reduction Method |
US20220214611A1 (en) * | 2019-04-16 | 2022-07-07 | Shin-Etsu Chemical Co., Ltd. | Pellicle, Exposure Original Plate with Pellicle, Method for Producing Semiconductor Device, Method for Producing Liquid Crystal Display Board, Method for Regenerating Exposure Original Plate, and Peeling Residue Reduction Method |
US20220113623A1 (en) * | 2020-10-14 | 2022-04-14 | Shin-Etsu Chemical Co., Ltd. | Agglutinant for Pellicles, Pellicle Frame with Agglutinant Layer, Pellicle, Exposure Original Plate with Pellicle, Exposure Method, Method for Producing Semiconductor, and Method for Producing Liquid Crystal Display Board |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220214611A1 (en) * | 2019-04-16 | 2022-07-07 | Shin-Etsu Chemical Co., Ltd. | Pellicle, Exposure Original Plate with Pellicle, Method for Producing Semiconductor Device, Method for Producing Liquid Crystal Display Board, Method for Regenerating Exposure Original Plate, and Peeling Residue Reduction Method |
US20220113623A1 (en) * | 2020-10-14 | 2022-04-14 | Shin-Etsu Chemical Co., Ltd. | Agglutinant for Pellicles, Pellicle Frame with Agglutinant Layer, Pellicle, Exposure Original Plate with Pellicle, Exposure Method, Method for Producing Semiconductor, and Method for Producing Liquid Crystal Display Board |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220214612A1 (en) | Agglutinant for Pellicle, Pellicle, Exposure Original Plate with Pellicle, Method for Producing Semiconductor Device, Method for Producing Liquid Crystal Display Board, Method for Regenerating Exposure Original Plate, and Peeling Residue Reduction Method | |
US20220113623A1 (en) | Agglutinant for Pellicles, Pellicle Frame with Agglutinant Layer, Pellicle, Exposure Original Plate with Pellicle, Exposure Method, Method for Producing Semiconductor, and Method for Producing Liquid Crystal Display Board | |
JP2012093518A (en) | Pellicle | |
TWI656192B (en) | Protective film (PELLICLE) | |
JP2020160466A (en) | Pellicle | |
JP7274636B2 (en) | pellicle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SHIN-ETSU CHEMICAL CO., LTD., JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HAMADA, YUICHI;NISHIMURA, AKINORI;REEL/FRAME:057828/0515 Effective date: 20211013 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |